Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061448 | 0.00000 | 5.12736 | 7 | 31 | 285 | connective tissue development |
| GO:0001503 | 0.00000 | 4.26424 | 9 | 35 | 381 | ossification |
| GO:0001501 | 0.00000 | 3.65334 | 13 | 42 | 530 | skeletal system development |
| GO:0051239 | 0.00000 | 2.01468 | 79 | 137 | 3248 | regulation of multicellular organismal process |
| GO:0032502 | 0.00000 | 1.78627 | 152 | 222 | 6258 | developmental process |
| GO:0007275 | 0.00000 | 1.81675 | 130 | 197 | 5362 | multicellular organism development |
| GO:0048856 | 0.00000 | 1.79383 | 143 | 211 | 5871 | anatomical structure development |
| GO:0050793 | 0.00000 | 2.05998 | 66 | 119 | 2721 | regulation of developmental process |
| GO:0009888 | 0.00000 | 2.23244 | 48 | 94 | 1956 | tissue development |
| GO:0048731 | 0.00000 | 1.84050 | 115 | 179 | 4746 | system development |
| GO:0051216 | 0.00000 | 5.33785 | 5 | 24 | 211 | cartilage development |
| GO:2000026 | 0.00000 | 2.04614 | 53 | 97 | 2184 | regulation of multicellular organismal development |
| GO:0043269 | 0.00000 | 2.84273 | 18 | 46 | 732 | regulation of ion transport |
| GO:0009653 | 0.00000 | 1.90606 | 67 | 113 | 2744 | anatomical structure morphogenesis |
| GO:0006812 | 0.00000 | 2.37414 | 27 | 58 | 1101 | cation transport |
| GO:0006811 | 0.00000 | 2.14275 | 38 | 74 | 1565 | ion transport |
| GO:0010646 | 0.00000 | 1.79622 | 81 | 129 | 3338 | regulation of cell communication |
| GO:0071363 | 0.00000 | 2.91377 | 15 | 39 | 602 | cellular response to growth factor stimulus |
| GO:0023051 | 0.00000 | 1.78197 | 82 | 129 | 3360 | regulation of signaling |
| GO:0007166 | 0.00000 | 1.89008 | 61 | 103 | 2497 | cell surface receptor signaling pathway |
| GO:0070848 | 0.00000 | 2.84633 | 15 | 39 | 615 | response to growth factor |
| GO:0032501 | 0.00000 | 1.58555 | 200 | 261 | 8233 | multicellular organismal process |
| GO:0007267 | 0.00000 | 2.09603 | 39 | 74 | 1596 | cell-cell signaling |
| GO:0007167 | 0.00000 | 2.46689 | 22 | 49 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0048705 | 0.00000 | 3.98581 | 6 | 23 | 262 | skeletal system morphogenesis |
| GO:0048513 | 0.00000 | 1.72869 | 85 | 131 | 3504 | animal organ development |
| GO:0048286 | 0.00000 | 8.98937 | 1 | 11 | 61 | lung alveolus development |
| GO:0007178 | 0.00000 | 3.40010 | 9 | 27 | 357 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0002062 | 0.00000 | 5.86547 | 3 | 15 | 120 | chondrocyte differentiation |
| GO:0030198 | 0.00000 | 3.83962 | 7 | 23 | 271 | extracellular matrix organization |
| GO:0060348 | 0.00000 | 4.13186 | 6 | 21 | 231 | bone development |
| GO:0043062 | 0.00000 | 3.57559 | 8 | 25 | 315 | extracellular structure organization |
| GO:0048468 | 0.00000 | 1.82944 | 58 | 97 | 2406 | cell development |
| GO:0060070 | 0.00000 | 3.71830 | 7 | 23 | 279 | canonical Wnt signaling pathway |
| GO:0042391 | 0.00000 | 3.05445 | 11 | 30 | 439 | regulation of membrane potential |
| GO:0009966 | 0.00000 | 1.77047 | 68 | 108 | 2780 | regulation of signal transduction |
| GO:0009887 | 0.00000 | 2.20861 | 26 | 54 | 1090 | animal organ morphogenesis |
| GO:1905114 | 0.00000 | 2.82183 | 13 | 33 | 521 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0090101 | 0.00000 | 5.79721 | 3 | 14 | 113 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0060828 | 0.00000 | 4.04448 | 5 | 20 | 224 | regulation of canonical Wnt signaling pathway |
| GO:0030001 | 0.00000 | 2.38625 | 20 | 45 | 839 | metal ion transport |
| GO:0065008 | 0.00000 | 1.64443 | 98 | 144 | 4051 | regulation of biological quality |
| GO:0007423 | 0.00000 | 2.64067 | 15 | 36 | 606 | sensory organ development |
| GO:0071495 | 0.00000 | 2.11352 | 30 | 58 | 1223 | cellular response to endogenous stimulus |
| GO:0060541 | 0.00000 | 3.76920 | 6 | 21 | 251 | respiratory system development |
| GO:0060349 | 0.00000 | 5.51727 | 3 | 14 | 118 | bone morphogenesis |
| GO:0032879 | 0.00000 | 1.72998 | 69 | 108 | 2835 | regulation of localization |
| GO:0090092 | 0.00000 | 3.87203 | 6 | 20 | 233 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006813 | 0.00000 | 3.85377 | 6 | 20 | 234 | potassium ion transport |
| GO:0030324 | 0.00000 | 3.91261 | 5 | 19 | 219 | lung development |
| GO:0071772 | 0.00000 | 4.31340 | 4 | 17 | 179 | response to BMP |
| GO:0071773 | 0.00000 | 4.31340 | 4 | 17 | 179 | cellular response to BMP stimulus |
| GO:0090288 | 0.00000 | 4.80661 | 3 | 15 | 143 | negative regulation of cellular response to growth factor stimulus |
| GO:0030323 | 0.00000 | 3.85427 | 5 | 19 | 222 | respiratory tube development |
| GO:0034765 | 0.00000 | 2.78366 | 12 | 30 | 478 | regulation of ion transmembrane transport |
| GO:0006936 | 0.00000 | 3.40214 | 7 | 22 | 289 | muscle contraction |
| GO:0015672 | 0.00000 | 2.82734 | 11 | 29 | 455 | monovalent inorganic cation transport |
| GO:0030509 | 0.00000 | 4.32078 | 4 | 16 | 168 | BMP signaling pathway |
| GO:0042221 | 0.00000 | 1.58673 | 101 | 143 | 4136 | response to chemical |
| GO:0007399 | 0.00000 | 1.75089 | 57 | 91 | 2333 | nervous system development |
| GO:0034762 | 0.00000 | 2.56847 | 14 | 33 | 568 | regulation of transmembrane transport |
| GO:0051049 | 0.00000 | 1.81287 | 47 | 79 | 1946 | regulation of transport |
| GO:0003012 | 0.00000 | 2.94188 | 10 | 26 | 392 | muscle system process |
| GO:0009719 | 0.00000 | 1.95290 | 34 | 62 | 1409 | response to endogenous stimulus |
| GO:0071804 | 0.00000 | 4.01378 | 5 | 17 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.00000 | 4.01378 | 5 | 17 | 191 | potassium ion transmembrane transport |
| GO:0010647 | 0.00000 | 1.82786 | 45 | 76 | 1854 | positive regulation of cell communication |
| GO:0030514 | 0.00000 | 8.32998 | 1 | 9 | 53 | negative regulation of BMP signaling pathway |
| GO:0023056 | 0.00001 | 1.82119 | 45 | 76 | 1860 | positive regulation of signaling |
| GO:0055085 | 0.00001 | 1.99345 | 31 | 57 | 1266 | transmembrane transport |
| GO:0032989 | 0.00001 | 2.00874 | 29 | 55 | 1211 | cellular component morphogenesis |
| GO:0010648 | 0.00001 | 1.96533 | 32 | 58 | 1306 | negative regulation of cell communication |
| GO:0035567 | 0.00001 | 7.79724 | 1 | 9 | 56 | non-canonical Wnt signaling pathway |
| GO:0023057 | 0.00001 | 1.95869 | 32 | 58 | 1310 | negative regulation of signaling |
| GO:0006024 | 0.00001 | 9.29538 | 1 | 8 | 43 | glycosaminoglycan biosynthetic process |
| GO:0030111 | 0.00001 | 3.19311 | 7 | 21 | 292 | regulation of Wnt signaling pathway |
| GO:0002063 | 0.00001 | 8.79214 | 1 | 8 | 45 | chondrocyte development |
| GO:0090287 | 0.00001 | 3.28026 | 7 | 20 | 271 | regulation of cellular response to growth factor stimulus |
| GO:0034220 | 0.00001 | 2.15586 | 21 | 43 | 878 | ion transmembrane transport |
| GO:0030182 | 0.00001 | 1.86426 | 36 | 63 | 1494 | neuron differentiation |
| GO:0060350 | 0.00001 | 6.17547 | 2 | 10 | 76 | endochondral bone morphogenesis |
| GO:0065007 | 0.00002 | 1.43951 | 295 | 344 | 12135 | biological regulation |
| GO:0098655 | 0.00002 | 2.29274 | 17 | 36 | 690 | cation transmembrane transport |
| GO:0048666 | 0.00002 | 1.94704 | 30 | 54 | 1222 | neuron development |
| GO:0000902 | 0.00002 | 2.00074 | 27 | 50 | 1100 | cell morphogenesis |
| GO:0060047 | 0.00002 | 3.59679 | 5 | 17 | 211 | heart contraction |
| GO:0009967 | 0.00002 | 1.85045 | 37 | 63 | 1504 | positive regulation of signal transduction |
| GO:0051960 | 0.00002 | 2.01314 | 26 | 49 | 1071 | regulation of nervous system development |
| GO:0023052 | 0.00002 | 1.45777 | 160 | 205 | 6579 | signaling |
| GO:0048699 | 0.00002 | 1.79850 | 41 | 68 | 1672 | generation of neurons |
| GO:0001508 | 0.00002 | 4.46630 | 3 | 13 | 132 | action potential |
| GO:0006029 | 0.00002 | 5.90619 | 2 | 10 | 79 | proteoglycan metabolic process |
| GO:0030282 | 0.00003 | 4.71196 | 3 | 12 | 116 | bone mineralization |
| GO:0042471 | 0.00003 | 4.32029 | 3 | 13 | 136 | ear morphogenesis |
| GO:0043583 | 0.00003 | 3.29994 | 6 | 18 | 242 | ear development |
| GO:0003015 | 0.00003 | 3.41895 | 5 | 17 | 221 | heart process |
| GO:0006941 | 0.00003 | 3.97763 | 4 | 14 | 158 | striated muscle contraction |
| GO:0060351 | 0.00003 | 7.39111 | 1 | 8 | 52 | cartilage development involved in endochondral bone morphogenesis |
| GO:0007154 | 0.00004 | 1.43604 | 162 | 205 | 6648 | cell communication |
| GO:0048583 | 0.00004 | 1.52351 | 94 | 131 | 3883 | regulation of response to stimulus |
| GO:0006023 | 0.00004 | 7.22654 | 1 | 8 | 53 | aminoglycan biosynthetic process |
| GO:0022603 | 0.00004 | 1.95620 | 26 | 48 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0016331 | 0.00004 | 3.67773 | 4 | 15 | 182 | morphogenesis of embryonic epithelium |
| GO:0045595 | 0.00004 | 1.71274 | 46 | 74 | 1909 | regulation of cell differentiation |
| GO:0022008 | 0.00004 | 1.73707 | 43 | 70 | 1778 | neurogenesis |
| GO:0009968 | 0.00005 | 1.90357 | 29 | 51 | 1175 | negative regulation of signal transduction |
| GO:0098662 | 0.00005 | 2.28437 | 15 | 32 | 613 | inorganic cation transmembrane transport |
| GO:0060048 | 0.00005 | 4.37384 | 3 | 12 | 124 | cardiac muscle contraction |
| GO:0048589 | 0.00005 | 2.11203 | 19 | 38 | 787 | developmental growth |
| GO:0061061 | 0.00005 | 2.18356 | 17 | 35 | 701 | muscle structure development |
| GO:0016055 | 0.00006 | 2.56000 | 10 | 25 | 428 | Wnt signaling pathway |
| GO:0071310 | 0.00006 | 1.62285 | 59 | 89 | 2433 | cellular response to organic substance |
| GO:0198738 | 0.00006 | 2.54713 | 10 | 25 | 430 | cell-cell signaling by wnt |
| GO:0030278 | 0.00006 | 3.22728 | 6 | 17 | 233 | regulation of ossification |
| GO:0040007 | 0.00007 | 1.91518 | 27 | 48 | 1097 | growth |
| GO:0048869 | 0.00007 | 1.47733 | 108 | 145 | 4443 | cellular developmental process |
| GO:0098660 | 0.00007 | 2.19689 | 16 | 33 | 656 | inorganic ion transmembrane transport |
| GO:0035265 | 0.00008 | 3.29340 | 5 | 16 | 215 | organ growth |
| GO:0050896 | 0.00008 | 1.38661 | 232 | 276 | 9531 | response to stimulus |
| GO:0007155 | 0.00009 | 1.82162 | 32 | 54 | 1298 | cell adhesion |
| GO:0002027 | 0.00009 | 4.90692 | 2 | 10 | 93 | regulation of heart rate |
| GO:0030154 | 0.00009 | 1.47410 | 102 | 138 | 4218 | cell differentiation |
| GO:0031175 | 0.00009 | 1.89628 | 26 | 47 | 1083 | neuron projection development |
| GO:0048598 | 0.00010 | 2.19136 | 15 | 32 | 637 | embryonic morphogenesis |
| GO:0042472 | 0.00011 | 4.35353 | 3 | 11 | 114 | inner ear morphogenesis |
| GO:0055123 | 0.00011 | 4.01354 | 3 | 12 | 134 | digestive system development |
| GO:0022610 | 0.00011 | 1.80320 | 32 | 54 | 1310 | biological adhesion |
| GO:0051241 | 0.00011 | 1.79180 | 33 | 55 | 1343 | negative regulation of multicellular organismal process |
| GO:0098868 | 0.00011 | 7.28486 | 1 | 7 | 46 | bone growth |
| GO:0060284 | 0.00012 | 1.87728 | 27 | 47 | 1093 | regulation of cell development |
| GO:0030510 | 0.00013 | 4.68048 | 2 | 10 | 97 | regulation of BMP signaling pathway |
| GO:0007354 | 0.00014 | 60.54545 | 0 | 3 | 5 | zygotic determination of anterior/posterior axis, embryo |
| GO:0070887 | 0.00014 | 1.52793 | 73 | 104 | 3023 | cellular response to chemical stimulus |
| GO:0044057 | 0.00016 | 2.19161 | 14 | 30 | 596 | regulation of system process |
| GO:0090090 | 0.00016 | 4.15106 | 3 | 11 | 119 | negative regulation of canonical Wnt signaling pathway |
| GO:0090596 | 0.00016 | 2.76476 | 7 | 19 | 301 | sensory organ morphogenesis |
| GO:0015893 | 0.00017 | 3.19530 | 5 | 15 | 207 | drug transport |
| GO:0035637 | 0.00018 | 3.79457 | 3 | 12 | 141 | multicellular organismal signaling |
| GO:0030029 | 0.00018 | 2.04118 | 18 | 35 | 746 | actin filament-based process |
| GO:0048565 | 0.00018 | 4.07523 | 3 | 11 | 121 | digestive tract development |
| GO:0030203 | 0.00018 | 4.94638 | 2 | 9 | 83 | glycosaminoglycan metabolic process |
| GO:2000027 | 0.00019 | 3.16208 | 5 | 15 | 209 | regulation of animal organ morphogenesis |
| GO:0003417 | 0.00021 | 8.10609 | 1 | 6 | 36 | growth plate cartilage development |
| GO:0051179 | 0.00021 | 1.39413 | 145 | 182 | 5950 | localization |
| GO:0048839 | 0.00022 | 3.12953 | 5 | 15 | 211 | inner ear development |
| GO:0006766 | 0.00026 | 5.32728 | 2 | 8 | 69 | vitamin metabolic process |
| GO:0070252 | 0.00026 | 4.69189 | 2 | 9 | 87 | actin-mediated cell contraction |
| GO:0090257 | 0.00027 | 2.93581 | 6 | 16 | 239 | regulation of muscle system process |
| GO:0009790 | 0.00028 | 1.76802 | 30 | 50 | 1231 | embryo development |
| GO:0010959 | 0.00029 | 2.37650 | 10 | 23 | 421 | regulation of metal ion transport |
| GO:0048812 | 0.00029 | 2.05173 | 16 | 32 | 677 | neuron projection morphogenesis |
| GO:0014821 | 0.00030 | 10.11896 | 1 | 5 | 25 | phasic smooth muscle contraction |
| GO:0042573 | 0.00030 | 10.11896 | 1 | 5 | 25 | retinoic acid metabolic process |
| GO:0016051 | 0.00030 | 3.17701 | 5 | 14 | 194 | carbohydrate biosynthetic process |
| GO:0030048 | 0.00030 | 4.15310 | 3 | 10 | 108 | actin filament-based movement |
| GO:0007517 | 0.00032 | 2.35841 | 10 | 23 | 424 | muscle organ development |
| GO:0048562 | 0.00032 | 2.60558 | 8 | 19 | 318 | embryonic organ morphogenesis |
| GO:0086001 | 0.00032 | 6.04274 | 1 | 7 | 54 | cardiac muscle cell action potential |
| GO:0048519 | 0.00034 | 1.39317 | 128 | 163 | 5278 | negative regulation of biological process |
| GO:0000904 | 0.00035 | 1.94229 | 20 | 36 | 804 | cell morphogenesis involved in differentiation |
| GO:0030166 | 0.00036 | 5.91659 | 1 | 7 | 55 | proteoglycan biosynthetic process |
| GO:0008015 | 0.00037 | 2.24201 | 12 | 25 | 484 | blood circulation |
| GO:0048585 | 0.00038 | 1.65929 | 38 | 60 | 1576 | negative regulation of response to stimulus |
| GO:0009312 | 0.00038 | 14.69805 | 0 | 4 | 15 | oligosaccharide biosynthetic process |
| GO:0016114 | 0.00038 | 14.69805 | 0 | 4 | 15 | terpenoid biosynthetic process |
| GO:0032990 | 0.00039 | 1.99242 | 17 | 33 | 718 | cell part morphogenesis |
| GO:0006937 | 0.00040 | 3.44519 | 4 | 12 | 154 | regulation of muscle contraction |
| GO:0006939 | 0.00041 | 3.98952 | 3 | 10 | 112 | smooth muscle contraction |
| GO:0008016 | 0.00041 | 3.23432 | 4 | 13 | 177 | regulation of heart contraction |
| GO:0034763 | 0.00041 | 3.67243 | 3 | 11 | 133 | negative regulation of transmembrane transport |
| GO:0120039 | 0.00042 | 2.00687 | 17 | 32 | 691 | plasma membrane bounded cell projection morphogenesis |
| GO:0010460 | 0.00043 | 9.19824 | 1 | 5 | 27 | positive regulation of heart rate |
| GO:0035989 | 0.00046 | 30.27005 | 0 | 3 | 7 | tendon development |
| GO:0042904 | 0.00046 | 30.27005 | 0 | 3 | 7 | 9-cis-retinoic acid biosynthetic process |
| GO:0042905 | 0.00046 | 30.27005 | 0 | 3 | 7 | 9-cis-retinoic acid metabolic process |
| GO:0071638 | 0.00046 | 30.27005 | 0 | 3 | 7 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0048858 | 0.00047 | 1.99130 | 17 | 32 | 696 | cell projection morphogenesis |
| GO:0048568 | 0.00048 | 2.19800 | 12 | 25 | 493 | embryonic organ development |
| GO:1903510 | 0.00050 | 5.56782 | 1 | 7 | 58 | mucopolysaccharide metabolic process |
| GO:0008272 | 0.00050 | 13.47262 | 0 | 4 | 16 | sulfate transport |
| GO:0050789 | 0.00050 | 1.33040 | 280 | 319 | 11520 | regulation of biological process |
| GO:0051093 | 0.00050 | 1.78303 | 26 | 44 | 1070 | negative regulation of developmental process |
| GO:0035270 | 0.00050 | 3.58381 | 3 | 11 | 136 | endocrine system development |
| GO:0003013 | 0.00051 | 2.18845 | 12 | 25 | 495 | circulatory system process |
| GO:0098739 | 0.00054 | 3.83829 | 3 | 10 | 116 | import across plasma membrane |
| GO:0015872 | 0.00055 | 5.46050 | 1 | 7 | 59 | dopamine transport |
| GO:0031214 | 0.00056 | 3.30464 | 4 | 12 | 160 | biomineral tissue development |
| GO:0003416 | 0.00057 | 6.57047 | 1 | 6 | 43 | endochondral bone growth |
| GO:0045823 | 0.00057 | 6.57047 | 1 | 6 | 43 | positive regulation of heart contraction |
| GO:0005985 | 0.00059 | Inf | 0 | 2 | 2 | sucrose metabolic process |
| GO:0005986 | 0.00059 | Inf | 0 | 2 | 2 | sucrose biosynthetic process |
| GO:0020028 | 0.00059 | Inf | 0 | 2 | 2 | endocytic hemoglobin import |
| GO:0060537 | 0.00060 | 2.20218 | 11 | 24 | 472 | muscle tissue development |
| GO:0042493 | 0.00065 | 1.83900 | 22 | 38 | 894 | response to drug |
| GO:0006814 | 0.00069 | 2.90066 | 5 | 14 | 211 | sodium ion transport |
| GO:0042127 | 0.00070 | 1.60816 | 40 | 61 | 1649 | regulation of cell proliferation |
| GO:0050654 | 0.00072 | 8.09338 | 1 | 5 | 30 | chondroitin sulfate proteoglycan metabolic process |
| GO:0019228 | 0.00073 | 6.23297 | 1 | 6 | 45 | neuronal action potential |
| GO:0006721 | 0.00075 | 5.16197 | 2 | 7 | 62 | terpenoid metabolic process |
| GO:0086003 | 0.00075 | 5.16197 | 2 | 7 | 62 | cardiac muscle cell contraction |
| GO:0051240 | 0.00077 | 1.55776 | 47 | 69 | 1929 | positive regulation of multicellular organismal process |
| GO:0048523 | 0.00077 | 1.37937 | 114 | 145 | 4687 | negative regulation of cellular process |
| GO:0006022 | 0.00080 | 3.97544 | 2 | 9 | 101 | aminoglycan metabolic process |
| GO:0090263 | 0.00080 | 3.97544 | 2 | 9 | 101 | positive regulation of canonical Wnt signaling pathway |
| GO:0021700 | 0.00082 | 2.46393 | 8 | 18 | 317 | developmental maturation |
| GO:0001505 | 0.00085 | 2.32850 | 9 | 20 | 372 | regulation of neurotransmitter levels |
| GO:0006720 | 0.00085 | 4.38888 | 2 | 8 | 82 | isoprenoid metabolic process |
| GO:0010033 | 0.00085 | 1.44574 | 75 | 101 | 3070 | response to organic substance |
| GO:0042445 | 0.00095 | 2.80025 | 5 | 14 | 218 | hormone metabolic process |
| GO:0051180 | 0.00097 | 7.49321 | 1 | 5 | 32 | vitamin transport |
| GO:1904062 | 0.00098 | 2.35754 | 8 | 19 | 349 | regulation of cation transmembrane transport |
| GO:0050954 | 0.00100 | 2.49152 | 7 | 17 | 296 | sensory perception of mechanical stimulus |
| GO:0050650 | 0.00100 | 10.77667 | 0 | 4 | 19 | chondroitin sulfate proteoglycan biosynthetic process |
| GO:1902259 | 0.00100 | 10.77667 | 0 | 4 | 19 | regulation of delayed rectifier potassium channel activity |
| GO:0006836 | 0.00103 | 2.48252 | 7 | 17 | 297 | neurotransmitter transport |
| GO:0034766 | 0.00105 | 3.80912 | 3 | 9 | 105 | negative regulation of ion transmembrane transport |
| GO:0006775 | 0.00113 | 7.22527 | 1 | 5 | 33 | fat-soluble vitamin metabolic process |
| GO:0048566 | 0.00113 | 7.22527 | 1 | 5 | 33 | embryonic digestive tract development |
| GO:0086091 | 0.00113 | 7.22527 | 1 | 5 | 33 | regulation of heart rate by cardiac conduction |
| GO:0007169 | 0.00114 | 2.02836 | 13 | 26 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0009611 | 0.00115 | 2.09247 | 12 | 24 | 495 | response to wounding |
| GO:0030178 | 0.00119 | 3.19770 | 4 | 11 | 151 | negative regulation of Wnt signaling pathway |
| GO:0050767 | 0.00119 | 1.76026 | 23 | 39 | 956 | regulation of neurogenesis |
| GO:0035725 | 0.00129 | 3.69320 | 3 | 9 | 108 | sodium ion transmembrane transport |
| GO:0009612 | 0.00129 | 2.98012 | 4 | 12 | 176 | response to mechanical stimulus |
| GO:0009311 | 0.00129 | 6.97582 | 1 | 5 | 34 | oligosaccharide metabolic process |
| GO:0099537 | 0.00129 | 1.79436 | 21 | 36 | 865 | trans-synaptic signaling |
| GO:0044283 | 0.00135 | 1.92251 | 16 | 29 | 650 | small molecule biosynthetic process |
| GO:0010721 | 0.00137 | 2.23183 | 9 | 20 | 387 | negative regulation of cell development |
| GO:0015844 | 0.00137 | 3.65611 | 3 | 9 | 109 | monoamine transport |
| GO:0051588 | 0.00142 | 2.94395 | 4 | 12 | 178 | regulation of neurotransmitter transport |
| GO:0060428 | 0.00143 | 5.40048 | 1 | 6 | 51 | lung epithelium development |
| GO:1904063 | 0.00146 | 4.00835 | 2 | 8 | 89 | negative regulation of cation transmembrane transport |
| GO:0030177 | 0.00146 | 3.33254 | 3 | 10 | 132 | positive regulation of Wnt signaling pathway |
| GO:0032412 | 0.00147 | 2.56156 | 6 | 15 | 254 | regulation of ion transmembrane transporter activity |
| GO:0006928 | 0.00150 | 1.50899 | 49 | 70 | 2014 | movement of cell or subcellular component |
| GO:0003149 | 0.00151 | 17.29488 | 0 | 3 | 10 | membranous septum morphogenesis |
| GO:0098598 | 0.00151 | 17.29488 | 0 | 3 | 10 | learned vocalization behavior or vocal learning |
| GO:0061564 | 0.00154 | 2.04371 | 12 | 24 | 506 | axon development |
| GO:0099536 | 0.00155 | 1.77435 | 21 | 36 | 874 | synaptic signaling |
| GO:0014706 | 0.00159 | 2.11213 | 11 | 22 | 449 | striated muscle tissue development |
| GO:1902533 | 0.00163 | 1.71507 | 24 | 40 | 1005 | positive regulation of intracellular signal transduction |
| GO:0048667 | 0.00164 | 1.91943 | 15 | 28 | 628 | cell morphogenesis involved in neuron differentiation |
| GO:0072348 | 0.00168 | 6.52519 | 1 | 5 | 36 | sulfur compound transport |
| GO:0051094 | 0.00170 | 1.57198 | 37 | 56 | 1540 | positive regulation of developmental process |
| GO:0035023 | 0.00173 | 3.25213 | 3 | 10 | 135 | regulation of Rho protein signal transduction |
| GO:0031589 | 0.00174 | 2.29280 | 8 | 18 | 339 | cell-substrate adhesion |
| GO:0060166 | 0.00174 | 80.58719 | 0 | 2 | 3 | olfactory pit development |
| GO:0061144 | 0.00174 | 80.58719 | 0 | 2 | 3 | alveolar secondary septum development |
| GO:1901629 | 0.00174 | 80.58719 | 0 | 2 | 3 | regulation of presynaptic membrane organization |
| GO:1902303 | 0.00174 | 80.58719 | 0 | 2 | 3 | negative regulation of potassium ion export |
| GO:1903765 | 0.00174 | 80.58719 | 0 | 2 | 3 | negative regulation of potassium ion export across plasma membrane |
| GO:0048546 | 0.00175 | 5.17021 | 1 | 6 | 53 | digestive tract morphogenesis |
| GO:0003433 | 0.00178 | 8.97937 | 1 | 4 | 22 | chondrocyte development involved in endochondral bone morphogenesis |
| GO:0009110 | 0.00178 | 8.97937 | 1 | 4 | 22 | vitamin biosynthetic process |
| GO:0021516 | 0.00178 | 8.97937 | 1 | 4 | 22 | dorsal spinal cord development |
| GO:0030204 | 0.00178 | 8.97937 | 1 | 4 | 22 | chondroitin sulfate metabolic process |
| GO:0043627 | 0.00181 | 4.36589 | 2 | 7 | 72 | response to estrogen |
| GO:0060071 | 0.00191 | 6.32100 | 1 | 5 | 37 | Wnt signaling pathway, planar cell polarity pathway |
| GO:0071514 | 0.00191 | 6.32100 | 1 | 5 | 37 | genetic imprinting |
| GO:0007610 | 0.00194 | 1.83154 | 18 | 31 | 728 | behavior |
| GO:0072175 | 0.00199 | 2.98319 | 4 | 11 | 161 | epithelial tube formation |
| GO:0022898 | 0.00199 | 2.47771 | 6 | 15 | 262 | regulation of transmembrane transporter activity |
| GO:0005975 | 0.00200 | 1.96969 | 13 | 25 | 546 | carbohydrate metabolic process |
| GO:0007268 | 0.00202 | 1.75883 | 21 | 35 | 856 | chemical synaptic transmission |
| GO:0098916 | 0.00202 | 1.75883 | 21 | 35 | 856 | anterograde trans-synaptic signaling |
| GO:0035556 | 0.00203 | 1.43562 | 63 | 86 | 2608 | intracellular signal transduction |
| GO:0009636 | 0.00204 | 2.25713 | 8 | 18 | 344 | response to toxic substance |
| GO:0002138 | 0.00204 | 15.13235 | 0 | 3 | 11 | retinoic acid biosynthetic process |
| GO:0016102 | 0.00204 | 15.13235 | 0 | 3 | 11 | diterpenoid biosynthetic process |
| GO:0030206 | 0.00204 | 15.13235 | 0 | 3 | 11 | chondroitin sulfate biosynthetic process |
| GO:0001523 | 0.00212 | 4.95874 | 1 | 6 | 55 | retinoid metabolic process |
| GO:0003044 | 0.00212 | 4.95874 | 1 | 6 | 55 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0008543 | 0.00213 | 4.23519 | 2 | 7 | 74 | fibroblast growth factor receptor signaling pathway |
| GO:0043267 | 0.00215 | 6.12918 | 1 | 5 | 38 | negative regulation of potassium ion transport |
| GO:0035295 | 0.00225 | 1.64968 | 27 | 43 | 1122 | tube development |
| GO:0051716 | 0.00231 | 1.28815 | 190 | 222 | 7810 | cellular response to stimulus |
| GO:0048646 | 0.00232 | 1.63704 | 28 | 44 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0072347 | 0.00232 | 4.85935 | 1 | 6 | 56 | response to anesthetic |
| GO:0016043 | 0.00233 | 1.30736 | 148 | 178 | 6083 | cellular component organization |
| GO:0065009 | 0.00234 | 1.43849 | 60 | 82 | 2477 | regulation of molecular function |
| GO:0006810 | 0.00236 | 1.34342 | 107 | 134 | 4398 | transport |
| GO:0099565 | 0.00236 | 3.68836 | 2 | 8 | 96 | chemical synaptic transmission, postsynaptic |
| GO:0090175 | 0.00242 | 5.94865 | 1 | 5 | 39 | regulation of establishment of planar polarity |
| GO:0051580 | 0.00249 | 8.08071 | 1 | 4 | 24 | regulation of neurotransmitter uptake |
| GO:0070167 | 0.00252 | 3.64675 | 2 | 8 | 97 | regulation of biomineral tissue development |
| GO:0016101 | 0.00255 | 4.76386 | 1 | 6 | 57 | diterpenoid metabolic process |
| GO:0032026 | 0.00267 | 13.45039 | 0 | 3 | 12 | response to magnesium ion |
| GO:0048570 | 0.00267 | 13.45039 | 0 | 3 | 12 | notochord morphogenesis |
| GO:0060430 | 0.00267 | 13.45039 | 0 | 3 | 12 | lung saccule development |
| GO:0001738 | 0.00267 | 4.05314 | 2 | 7 | 77 | morphogenesis of a polarized epithelium |
| GO:0008285 | 0.00268 | 1.82852 | 17 | 29 | 681 | negative regulation of cell proliferation |
| GO:0007165 | 0.00276 | 1.30176 | 146 | 176 | 6028 | signal transduction |
| GO:0050890 | 0.00277 | 2.24661 | 8 | 17 | 326 | cognition |
| GO:2001257 | 0.00277 | 2.84930 | 4 | 11 | 168 | regulation of cation channel activity |
| GO:1901135 | 0.00278 | 1.67081 | 24 | 39 | 1003 | carbohydrate derivative metabolic process |
| GO:0032409 | 0.00285 | 2.38024 | 7 | 15 | 272 | regulation of transporter activity |
| GO:0008284 | 0.00286 | 1.67939 | 24 | 38 | 972 | positive regulation of cell proliferation |
| GO:0030325 | 0.00291 | 7.69558 | 1 | 4 | 25 | adrenal gland development |
| GO:0030903 | 0.00291 | 7.69558 | 1 | 4 | 25 | notochord development |
| GO:0048148 | 0.00291 | 7.69558 | 1 | 4 | 25 | behavioral response to cocaine |
| GO:0071234 | 0.00291 | 7.69558 | 1 | 4 | 25 | cellular response to phenylalanine |
| GO:0080053 | 0.00291 | 7.69558 | 1 | 4 | 25 | response to phenylalanine |
| GO:0060429 | 0.00294 | 1.61414 | 28 | 44 | 1172 | epithelium development |
| GO:0015837 | 0.00298 | 3.23363 | 3 | 9 | 122 | amine transport |
| GO:0009987 | 0.00313 | 1.30153 | 384 | 414 | 15803 | cellular process |
| GO:0030500 | 0.00332 | 3.88606 | 2 | 7 | 80 | regulation of bone mineralization |
| GO:0042220 | 0.00337 | 5.46560 | 1 | 5 | 42 | response to cocaine |
| GO:0048799 | 0.00337 | 7.34545 | 1 | 4 | 26 | animal organ maturation |
| GO:1901380 | 0.00337 | 7.34545 | 1 | 4 | 26 | negative regulation of potassium ion transmembrane transport |
| GO:0007351 | 0.00340 | 12.10481 | 0 | 3 | 13 | tripartite regional subdivision |
| GO:0008595 | 0.00340 | 12.10481 | 0 | 3 | 13 | anterior/posterior axis specification, embryo |
| GO:0031223 | 0.00340 | 12.10481 | 0 | 3 | 13 | auditory behavior |
| GO:0097090 | 0.00340 | 12.10481 | 0 | 3 | 13 | presynaptic membrane organization |
| GO:1904396 | 0.00340 | 12.10481 | 0 | 3 | 13 | regulation of neuromuscular junction development |
| GO:0001996 | 0.00342 | 40.29181 | 0 | 2 | 4 | positive regulation of heart rate by epinephrine-norepinephrine |
| GO:0001997 | 0.00342 | 40.29181 | 0 | 2 | 4 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
| GO:0003099 | 0.00342 | 40.29181 | 0 | 2 | 4 | positive regulation of the force of heart contraction by chemical signal |
| GO:0015755 | 0.00342 | 40.29181 | 0 | 2 | 4 | fructose transmembrane transport |
| GO:0046351 | 0.00342 | 40.29181 | 0 | 2 | 4 | disaccharide biosynthetic process |
| GO:1904684 | 0.00342 | 40.29181 | 0 | 2 | 4 | negative regulation of metalloendopeptidase activity |
| GO:0048469 | 0.00343 | 2.62506 | 5 | 12 | 198 | cell maturation |
| GO:0051051 | 0.00356 | 1.90612 | 13 | 24 | 540 | negative regulation of transport |
| GO:0001649 | 0.00358 | 2.61090 | 5 | 12 | 199 | osteoblast differentiation |
| GO:0032970 | 0.00372 | 2.07608 | 10 | 19 | 393 | regulation of actin filament-based process |
| GO:0086002 | 0.00374 | 5.32153 | 1 | 5 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:0035107 | 0.00379 | 2.72683 | 4 | 11 | 175 | appendage morphogenesis |
| GO:0035108 | 0.00379 | 2.72683 | 4 | 11 | 175 | limb morphogenesis |
| GO:0048736 | 0.00387 | 2.58305 | 5 | 12 | 201 | appendage development |
| GO:0060173 | 0.00387 | 2.58305 | 5 | 12 | 201 | limb development |
| GO:0090103 | 0.00388 | 7.02578 | 1 | 4 | 27 | cochlea morphogenesis |
| GO:0048640 | 0.00390 | 3.09592 | 3 | 9 | 127 | negative regulation of developmental growth |
| GO:0035148 | 0.00396 | 2.71019 | 4 | 11 | 176 | tube formation |
| GO:0009100 | 0.00399 | 2.16146 | 8 | 17 | 338 | glycoprotein metabolic process |
| GO:0051234 | 0.00400 | 1.31694 | 110 | 136 | 4538 | establishment of localization |
| GO:0006942 | 0.00407 | 3.73216 | 2 | 7 | 83 | regulation of striated muscle contraction |
| GO:0014897 | 0.00411 | 3.34480 | 3 | 8 | 105 | striated muscle hypertrophy |
| GO:0043266 | 0.00411 | 3.34480 | 3 | 8 | 105 | regulation of potassium ion transport |
| GO:0001654 | 0.00415 | 2.05374 | 10 | 19 | 397 | eye development |
| GO:0045596 | 0.00420 | 1.71581 | 19 | 32 | 799 | negative regulation of cell differentiation |
| GO:0042362 | 0.00425 | 11.00389 | 0 | 3 | 14 | fat-soluble vitamin biosynthetic process |
| GO:0048484 | 0.00425 | 11.00389 | 0 | 3 | 14 | enteric nervous system development |
| GO:0070863 | 0.00425 | 11.00389 | 0 | 3 | 14 | positive regulation of protein exit from endoplasmic reticulum |
| GO:0071340 | 0.00425 | 11.00389 | 0 | 3 | 14 | skeletal muscle acetylcholine-gated channel clustering |
| GO:1901379 | 0.00435 | 3.68353 | 2 | 7 | 84 | regulation of potassium ion transmembrane transport |
| GO:0086005 | 0.00444 | 6.73274 | 1 | 4 | 28 | ventricular cardiac muscle cell action potential |
| GO:0045926 | 0.00447 | 2.33702 | 6 | 14 | 258 | negative regulation of growth |
| GO:0150063 | 0.00449 | 2.03730 | 10 | 19 | 400 | visual system development |
| GO:0001838 | 0.00450 | 2.82065 | 4 | 10 | 154 | embryonic epithelial tube formation |
| GO:0009880 | 0.00456 | 4.18762 | 2 | 6 | 64 | embryonic pattern specification |
| GO:0014046 | 0.00456 | 5.05501 | 1 | 5 | 45 | dopamine secretion |
| GO:0014059 | 0.00456 | 5.05501 | 1 | 5 | 45 | regulation of dopamine secretion |
| GO:0014896 | 0.00461 | 3.27694 | 3 | 8 | 107 | muscle hypertrophy |
| GO:0051056 | 0.00462 | 2.32738 | 6 | 14 | 259 | regulation of small GTPase mediated signal transduction |
| GO:0002088 | 0.00465 | 3.63615 | 2 | 7 | 85 | lens development in camera-type eye |
| GO:0048729 | 0.00468 | 1.77057 | 16 | 28 | 677 | tissue morphogenesis |
| GO:0015696 | 0.00478 | 2.99389 | 3 | 9 | 131 | ammonium transport |
| GO:0048880 | 0.00486 | 2.02111 | 10 | 19 | 403 | sensory system development |
| GO:0007596 | 0.00492 | 2.78176 | 4 | 10 | 156 | blood coagulation |
| GO:0060079 | 0.00495 | 3.58996 | 2 | 7 | 86 | excitatory postsynaptic potential |
| GO:0003413 | 0.00506 | 6.46314 | 1 | 4 | 29 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0071880 | 0.00506 | 6.46314 | 1 | 4 | 29 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0010817 | 0.00521 | 1.84390 | 14 | 24 | 557 | regulation of hormone levels |
| GO:0021781 | 0.00522 | 10.08645 | 0 | 3 | 15 | glial cell fate commitment |
| GO:0046541 | 0.00522 | 10.08645 | 0 | 3 | 15 | saliva secretion |
| GO:0051127 | 0.00522 | 10.08645 | 0 | 3 | 15 | positive regulation of actin nucleation |
| GO:0070307 | 0.00522 | 10.08645 | 0 | 3 | 15 | lens fiber cell development |
| GO:0043010 | 0.00532 | 2.09522 | 8 | 17 | 348 | camera-type eye development |
| GO:0007599 | 0.00538 | 2.74393 | 4 | 10 | 158 | hemostasis |
| GO:0007601 | 0.00538 | 2.74393 | 4 | 10 | 158 | visual perception |
| GO:0007611 | 0.00548 | 2.20641 | 7 | 15 | 292 | learning or memory |
| GO:0001504 | 0.00551 | 4.81387 | 1 | 5 | 47 | neurotransmitter uptake |
| GO:0006682 | 0.00561 | 26.86002 | 0 | 2 | 5 | galactosylceramide biosynthetic process |
| GO:0014734 | 0.00561 | 26.86002 | 0 | 2 | 5 | skeletal muscle hypertrophy |
| GO:0018101 | 0.00561 | 26.86002 | 0 | 2 | 5 | protein citrullination |
| GO:0019375 | 0.00561 | 26.86002 | 0 | 2 | 5 | galactolipid biosynthetic process |
| GO:0019532 | 0.00561 | 26.86002 | 0 | 2 | 5 | oxalate transport |
| GO:0036414 | 0.00561 | 26.86002 | 0 | 2 | 5 | histone citrullination |
| GO:0060392 | 0.00561 | 26.86002 | 0 | 2 | 5 | negative regulation of SMAD protein signal transduction |
| GO:0070640 | 0.00561 | 26.86002 | 0 | 2 | 5 | vitamin D3 metabolic process |
| GO:0106071 | 0.00561 | 26.86002 | 0 | 2 | 5 | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0044344 | 0.00562 | 3.50101 | 2 | 7 | 88 | cellular response to fibroblast growth factor stimulus |
| GO:0042552 | 0.00562 | 2.72539 | 4 | 10 | 159 | myelination |
| GO:0050817 | 0.00562 | 2.72539 | 4 | 10 | 159 | coagulation |
| GO:0120036 | 0.00568 | 1.49085 | 37 | 53 | 1526 | plasma membrane bounded cell projection organization |
| GO:0010810 | 0.00568 | 2.45215 | 5 | 12 | 211 | regulation of cell-substrate adhesion |
| GO:0043113 | 0.00571 | 3.98114 | 2 | 6 | 67 | receptor clustering |
| GO:2000179 | 0.00571 | 3.98114 | 2 | 6 | 67 | positive regulation of neural precursor cell proliferation |
| GO:0061037 | 0.00573 | 6.21429 | 1 | 4 | 30 | negative regulation of cartilage development |
| GO:0070306 | 0.00573 | 6.21429 | 1 | 4 | 30 | lens fiber cell differentiation |
| GO:0043270 | 0.00575 | 2.13158 | 8 | 16 | 322 | positive regulation of ion transport |
| GO:0007409 | 0.00581 | 1.91191 | 11 | 21 | 470 | axonogenesis |
| GO:0007605 | 0.00582 | 2.26202 | 6 | 14 | 266 | sensory perception of sound |
| GO:0010001 | 0.00591 | 2.34056 | 6 | 13 | 239 | glial cell differentiation |
| GO:1903522 | 0.00591 | 2.34056 | 6 | 13 | 239 | regulation of blood circulation |
| GO:0019226 | 0.00597 | 3.45816 | 2 | 7 | 89 | transmission of nerve impulse |
| GO:0051937 | 0.00597 | 3.45816 | 2 | 7 | 89 | catecholamine transport |
| GO:1903115 | 0.00603 | 4.70171 | 1 | 5 | 48 | regulation of actin filament-based movement |
| GO:0060078 | 0.00605 | 3.11871 | 3 | 8 | 112 | regulation of postsynaptic membrane potential |
| GO:1905330 | 0.00605 | 3.11871 | 3 | 8 | 112 | regulation of morphogenesis of an epithelium |
| GO:0008283 | 0.00631 | 1.42415 | 48 | 66 | 1994 | cell proliferation |
| GO:0007638 | 0.00631 | 9.31016 | 0 | 3 | 16 | mechanosensory behavior |
| GO:0043584 | 0.00631 | 9.31016 | 0 | 3 | 16 | nose development |
| GO:0060026 | 0.00631 | 9.31016 | 0 | 3 | 16 | convergent extension |
| GO:0090177 | 0.00631 | 9.31016 | 0 | 3 | 16 | establishment of planar polarity involved in neural tube closure |
| GO:0071774 | 0.00634 | 3.41634 | 2 | 7 | 90 | response to fibroblast growth factor |
| GO:0040011 | 0.00638 | 1.44270 | 44 | 61 | 1817 | locomotion |
| GO:0007272 | 0.00639 | 2.67124 | 4 | 10 | 162 | ensheathment of neurons |
| GO:0008366 | 0.00639 | 2.67124 | 4 | 10 | 162 | axon ensheathment |
| GO:0050953 | 0.00639 | 2.67124 | 4 | 10 | 162 | sensory perception of light stimulus |
| GO:0001958 | 0.00645 | 5.98386 | 1 | 4 | 31 | endochondral ossification |
| GO:0002026 | 0.00645 | 5.98386 | 1 | 4 | 31 | regulation of the force of heart contraction |
| GO:0008299 | 0.00645 | 5.98386 | 1 | 4 | 31 | isoprenoid biosynthetic process |
| GO:0036075 | 0.00645 | 5.98386 | 1 | 4 | 31 | replacement ossification |
| GO:0071875 | 0.00645 | 5.98386 | 1 | 4 | 31 | adrenergic receptor signaling pathway |
| GO:0086010 | 0.00645 | 5.98386 | 1 | 4 | 31 | membrane depolarization during action potential |
| GO:0090102 | 0.00658 | 4.59465 | 1 | 5 | 49 | cochlea development |
| GO:0007492 | 0.00659 | 3.85441 | 2 | 6 | 69 | endoderm development |
| GO:0055117 | 0.00659 | 3.85441 | 2 | 6 | 69 | regulation of cardiac muscle contraction |
| GO:0061035 | 0.00659 | 3.85441 | 2 | 6 | 69 | regulation of cartilage development |
| GO:0030036 | 0.00661 | 1.74001 | 16 | 27 | 663 | actin cytoskeleton organization |
| GO:0046903 | 0.00662 | 1.53516 | 30 | 44 | 1227 | secretion |
| GO:0048660 | 0.00666 | 2.65367 | 4 | 10 | 163 | regulation of smooth muscle cell proliferation |
| GO:0060419 | 0.00672 | 3.05959 | 3 | 8 | 114 | heart growth |
| GO:0071695 | 0.00696 | 2.49666 | 5 | 11 | 190 | anatomical structure maturation |
| GO:0051924 | 0.00703 | 2.20882 | 7 | 14 | 272 | regulation of calcium ion transport |
| GO:0051270 | 0.00707 | 1.58030 | 25 | 38 | 1028 | regulation of cellular component movement |
| GO:0005976 | 0.00707 | 3.03086 | 3 | 8 | 115 | polysaccharide metabolic process |
| GO:2001023 | 0.00707 | 3.03086 | 3 | 8 | 115 | regulation of response to drug |
| GO:0048584 | 0.00714 | 1.38952 | 56 | 74 | 2294 | positive regulation of response to stimulus |
| GO:0048608 | 0.00724 | 1.90397 | 11 | 20 | 449 | reproductive structure development |
| GO:0042060 | 0.00737 | 2.02083 | 9 | 17 | 360 | wound healing |
| GO:0015849 | 0.00739 | 2.12858 | 7 | 15 | 302 | organic acid transport |
| GO:0048522 | 0.00750 | 1.27022 | 133 | 158 | 5469 | positive regulation of cellular process |
| GO:0007350 | 0.00753 | 8.64477 | 0 | 3 | 17 | blastoderm segmentation |
| GO:1900452 | 0.00753 | 8.64477 | 0 | 3 | 17 | regulation of long-term synaptic depression |
| GO:0051961 | 0.00757 | 2.01487 | 9 | 17 | 361 | negative regulation of nervous system development |
| GO:0046394 | 0.00777 | 2.00894 | 9 | 17 | 362 | carboxylic acid biosynthetic process |
| GO:0045912 | 0.00779 | 4.39449 | 1 | 5 | 51 | negative regulation of carbohydrate metabolic process |
| GO:0016477 | 0.00783 | 1.47962 | 35 | 50 | 1447 | cell migration |
| GO:0061458 | 0.00794 | 1.88604 | 11 | 20 | 453 | reproductive system development |
| GO:0016053 | 0.00797 | 2.00304 | 9 | 17 | 363 | organic acid biosynthetic process |
| GO:0001706 | 0.00808 | 5.57069 | 1 | 4 | 33 | endoderm formation |
| GO:0048659 | 0.00818 | 2.56912 | 4 | 10 | 168 | smooth muscle cell proliferation |
| GO:0051952 | 0.00822 | 2.94781 | 3 | 8 | 118 | regulation of amine transport |
| GO:0005984 | 0.00829 | 20.14413 | 0 | 2 | 6 | disaccharide metabolic process |
| GO:0038031 | 0.00829 | 20.14413 | 0 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0042427 | 0.00829 | 20.14413 | 0 | 2 | 6 | serotonin biosynthetic process |
| GO:0046476 | 0.00829 | 20.14413 | 0 | 2 | 6 | glycosylceramide biosynthetic process |
| GO:0051611 | 0.00829 | 20.14413 | 0 | 2 | 6 | regulation of serotonin uptake |
| GO:0070447 | 0.00829 | 20.14413 | 0 | 2 | 6 | positive regulation of oligodendrocyte progenitor proliferation |
| GO:0071286 | 0.00829 | 20.14413 | 0 | 2 | 6 | cellular response to magnesium ion |
| GO:0090080 | 0.00829 | 20.14413 | 0 | 2 | 6 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway |
| GO:0097070 | 0.00829 | 20.14413 | 0 | 2 | 6 | ductus arteriosus closure |
| GO:1901162 | 0.00829 | 20.14413 | 0 | 2 | 6 | primary amino compound biosynthetic process |
| GO:1903026 | 0.00829 | 20.14413 | 0 | 2 | 6 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1904683 | 0.00829 | 20.14413 | 0 | 2 | 6 | regulation of metalloendopeptidase activity |
| GO:1904753 | 0.00829 | 20.14413 | 0 | 2 | 6 | negative regulation of vascular associated smooth muscle cell migration |
| GO:1905049 | 0.00829 | 20.14413 | 0 | 2 | 6 | negative regulation of metallopeptidase activity |
| GO:0071840 | 0.00837 | 1.25420 | 152 | 178 | 6266 | cellular component organization or biogenesis |
| GO:0007266 | 0.00839 | 2.42828 | 5 | 11 | 195 | Rho protein signal transduction |
| GO:0044092 | 0.00842 | 1.57060 | 24 | 37 | 1006 | negative regulation of molecular function |
| GO:0043436 | 0.00870 | 1.58761 | 23 | 35 | 941 | oxoacid metabolic process |
| GO:0050768 | 0.00873 | 2.03061 | 8 | 16 | 337 | negative regulation of neurogenesis |
| GO:0045664 | 0.00881 | 1.64925 | 19 | 30 | 776 | regulation of neuron differentiation |
| GO:0005980 | 0.00887 | 8.06809 | 0 | 3 | 18 | glycogen catabolic process |
| GO:0009251 | 0.00887 | 8.06809 | 0 | 3 | 18 | glucan catabolic process |
| GO:0042249 | 0.00887 | 8.06809 | 0 | 3 | 18 | establishment of planar polarity of embryonic epithelium |
| GO:0071435 | 0.00887 | 8.06809 | 0 | 3 | 18 | potassium ion export |
| GO:0086011 | 0.00887 | 8.06809 | 0 | 3 | 18 | membrane repolarization during action potential |
| GO:0097623 | 0.00887 | 8.06809 | 0 | 3 | 18 | potassium ion export across plasma membrane |
| GO:0099150 | 0.00887 | 8.06809 | 0 | 3 | 18 | regulation of postsynaptic specialization assembly |
| GO:0150052 | 0.00887 | 8.06809 | 0 | 3 | 18 | regulation of postsynapse assembly |
| GO:0030279 | 0.00895 | 3.18518 | 2 | 7 | 96 | negative regulation of ossification |
| GO:0044275 | 0.00898 | 5.38476 | 1 | 4 | 34 | cellular carbohydrate catabolic process |
| GO:0097366 | 0.00898 | 5.38476 | 1 | 4 | 34 | response to bronchodilator |
| GO:0099068 | 0.00898 | 5.38476 | 1 | 4 | 34 | postsynapse assembly |
| GO:0140115 | 0.00898 | 5.38476 | 1 | 4 | 34 | export across plasma membrane |
| GO:0048662 | 0.00915 | 4.21102 | 1 | 5 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:0055010 | 0.00915 | 4.21102 | 1 | 5 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0051259 | 0.00930 | 1.72789 | 15 | 25 | 617 | protein complex oligomerization |
| GO:0006468 | 0.00930 | 1.41711 | 44 | 60 | 1815 | protein phosphorylation |
| GO:0022604 | 0.00948 | 1.79416 | 13 | 22 | 523 | regulation of cell morphogenesis |
| GO:0023061 | 0.00948 | 1.79416 | 13 | 22 | 523 | signal release |
| GO:1990823 | 0.00953 | 2.06303 | 8 | 15 | 311 | response to leukemia inhibitory factor |
| GO:1990830 | 0.00953 | 2.06303 | 8 | 15 | 311 | cellular response to leukemia inhibitory factor |
| GO:0051962 | 0.00963 | 1.70274 | 16 | 26 | 651 | positive regulation of nervous system development |
| GO:0048638 | 0.00975 | 1.91631 | 10 | 18 | 401 | regulation of developmental growth |
| GO:0040008 | 0.00984 | 1.66474 | 17 | 28 | 717 | regulation of growth |
| GO:0030199 | 0.00989 | 4.12490 | 1 | 5 | 54 | collagen fibril organization |
| GO:0030030 | 0.00992 | 1.44256 | 38 | 53 | 1572 | cell projection organization |
| GO:0051100 | 0.00994 | 2.48976 | 4 | 10 | 173 | negative regulation of binding |
| GO:0009954 | 0.00995 | 5.21083 | 1 | 4 | 35 | proximal/distal pattern formation |
| GO:0031279 | 0.00995 | 5.21083 | 1 | 4 | 35 | regulation of cyclase activity |
| GO:0045686 | 0.00995 | 5.21083 | 1 | 4 | 35 | negative regulation of glial cell differentiation |
| GO:0044262 | 0.01006 | 2.10952 | 7 | 14 | 284 | cellular carbohydrate metabolic process |
| GO:0046578 | 0.01023 | 2.25745 | 6 | 12 | 228 | regulation of Ras protein signal transduction |
| GO:0044281 | 0.01031 | 1.41681 | 43 | 58 | 1753 | small molecule metabolic process |
| GO:0001502 | 0.01035 | 7.56350 | 0 | 3 | 19 | cartilage condensation |
| GO:0001975 | 0.01035 | 7.56350 | 0 | 3 | 19 | response to amphetamine |
| GO:0048712 | 0.01035 | 7.56350 | 0 | 3 | 19 | negative regulation of astrocyte differentiation |
| GO:0071605 | 0.01035 | 7.56350 | 0 | 3 | 19 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.01035 | 7.56350 | 0 | 3 | 19 | regulation of monocyte chemotactic protein-1 production |
| GO:0048844 | 0.01044 | 3.46790 | 2 | 6 | 76 | artery morphogenesis |
| GO:0033555 | 0.01051 | 3.08091 | 2 | 7 | 99 | multicellular organismal response to stress |
| GO:1901617 | 0.01057 | 2.24694 | 6 | 12 | 229 | organic hydroxy compound biosynthetic process |
| GO:0098742 | 0.01076 | 2.33855 | 5 | 11 | 202 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0003401 | 0.01098 | 5.04777 | 1 | 4 | 36 | axis elongation |
| GO:0071320 | 0.01098 | 5.04777 | 1 | 4 | 36 | cellular response to cAMP |
| GO:0045778 | 0.01107 | 3.04764 | 2 | 7 | 100 | positive regulation of ossification |
| GO:0055013 | 0.01107 | 3.04764 | 2 | 7 | 100 | cardiac muscle cell development |
| GO:0007389 | 0.01108 | 1.82166 | 11 | 20 | 468 | pattern specification process |
| GO:0003057 | 0.01142 | 16.11459 | 0 | 2 | 7 | regulation of the force of heart contraction by chemical signal |
| GO:0003321 | 0.01142 | 16.11459 | 0 | 2 | 7 | positive regulation of blood pressure by epinephrine-norepinephrine |
| GO:0035864 | 0.01142 | 16.11459 | 0 | 2 | 7 | response to potassium ion |
| GO:0035865 | 0.01142 | 16.11459 | 0 | 2 | 7 | cellular response to potassium ion |
| GO:0038030 | 0.01142 | 16.11459 | 0 | 2 | 7 | non-canonical Wnt signaling pathway via MAPK cascade |
| GO:0042297 | 0.01142 | 16.11459 | 0 | 2 | 7 | vocal learning |
| GO:0051610 | 0.01142 | 16.11459 | 0 | 2 | 7 | serotonin uptake |
| GO:0060372 | 0.01142 | 16.11459 | 0 | 2 | 7 | regulation of atrial cardiac muscle cell membrane repolarization |
| GO:0060385 | 0.01142 | 16.11459 | 0 | 2 | 7 | axonogenesis involved in innervation |
| GO:0060501 | 0.01142 | 16.11459 | 0 | 2 | 7 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0061156 | 0.01142 | 16.11459 | 0 | 2 | 7 | pulmonary artery morphogenesis |
| GO:0098596 | 0.01142 | 16.11459 | 0 | 2 | 7 | imitative learning |
| GO:0098915 | 0.01142 | 16.11459 | 0 | 2 | 7 | membrane repolarization during ventricular cardiac muscle cell action potential |
| GO:1902302 | 0.01142 | 16.11459 | 0 | 2 | 7 | regulation of potassium ion export |
| GO:1903764 | 0.01142 | 16.11459 | 0 | 2 | 7 | regulation of potassium ion export across plasma membrane |
| GO:0099175 | 0.01142 | 2.77058 | 3 | 8 | 125 | regulation of postsynapse organization |
| GO:0007160 | 0.01152 | 2.31411 | 5 | 11 | 204 | cell-matrix adhesion |
| GO:0048738 | 0.01152 | 2.13955 | 6 | 13 | 260 | cardiac muscle tissue development |
| GO:0050804 | 0.01155 | 1.67516 | 16 | 26 | 661 | modulation of chemical synaptic transmission |
| GO:0099177 | 0.01175 | 1.67245 | 16 | 26 | 662 | regulation of trans-synaptic signaling |
| GO:0006688 | 0.01196 | 7.11828 | 0 | 3 | 20 | glycosphingolipid biosynthetic process |
| GO:0014075 | 0.01196 | 7.11828 | 0 | 3 | 20 | response to amine |
| GO:0044247 | 0.01196 | 7.11828 | 0 | 3 | 20 | cellular polysaccharide catabolic process |
| GO:0051481 | 0.01196 | 7.11828 | 0 | 3 | 20 | negative regulation of cytosolic calcium ion concentration |
| GO:0060307 | 0.01196 | 7.11828 | 0 | 3 | 20 | regulation of ventricular cardiac muscle cell membrane repolarization |
| GO:0072079 | 0.01196 | 7.11828 | 0 | 3 | 20 | nephron tubule formation |
| GO:0098743 | 0.01196 | 7.11828 | 0 | 3 | 20 | cell aggregation |
| GO:0071391 | 0.01208 | 4.89459 | 1 | 4 | 37 | cellular response to estrogen stimulus |
| GO:0086065 | 0.01208 | 4.89459 | 1 | 4 | 37 | cell communication involved in cardiac conduction |
| GO:0016310 | 0.01215 | 1.36595 | 53 | 69 | 2166 | phosphorylation |
| GO:0050806 | 0.01221 | 1.95043 | 9 | 16 | 350 | positive regulation of synaptic transmission |
| GO:0050886 | 0.01226 | 2.98322 | 2 | 7 | 102 | endocrine process |
| GO:0060538 | 0.01232 | 2.29017 | 5 | 11 | 206 | skeletal muscle organ development |
| GO:0001736 | 0.01234 | 3.88640 | 1 | 5 | 57 | establishment of planar polarity |
| GO:0050879 | 0.01234 | 3.88640 | 1 | 5 | 57 | multicellular organismal movement |
| GO:0050881 | 0.01234 | 3.88640 | 1 | 5 | 57 | musculoskeletal movement |
| GO:0033002 | 0.01238 | 2.19585 | 6 | 12 | 234 | muscle cell proliferation |
| GO:0010811 | 0.01249 | 2.72378 | 3 | 8 | 127 | positive regulation of cell-substrate adhesion |
| GO:0017015 | 0.01288 | 2.95201 | 3 | 7 | 103 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0043255 | 0.01288 | 2.95201 | 3 | 7 | 103 | regulation of carbohydrate biosynthetic process |
| GO:0048709 | 0.01288 | 2.95201 | 3 | 7 | 103 | oligodendrocyte differentiation |
| GO:0032940 | 0.01290 | 1.51305 | 26 | 38 | 1070 | secretion by cell |
| GO:0006082 | 0.01299 | 1.53975 | 24 | 35 | 968 | organic acid metabolic process |
| GO:0032410 | 0.01324 | 3.27986 | 2 | 6 | 80 | negative regulation of transporter activity |
| GO:0007164 | 0.01324 | 3.81291 | 1 | 5 | 58 | establishment of tissue polarity |
| GO:0061337 | 0.01324 | 3.81291 | 1 | 5 | 58 | cardiac conduction |
| GO:0001953 | 0.01325 | 4.75042 | 1 | 4 | 38 | negative regulation of cell-matrix adhesion |
| GO:0051339 | 0.01325 | 4.75042 | 1 | 4 | 38 | regulation of lyase activity |
| GO:1903825 | 0.01353 | 2.92145 | 3 | 7 | 104 | organic acid transmembrane transport |
| GO:1905039 | 0.01353 | 2.92145 | 3 | 7 | 104 | carboxylic acid transmembrane transport |
| GO:0032682 | 0.01370 | 6.72252 | 1 | 3 | 21 | negative regulation of chemokine production |
| GO:0050807 | 0.01372 | 2.08825 | 6 | 13 | 266 | regulation of synapse organization |
| GO:0043408 | 0.01379 | 1.61631 | 18 | 28 | 737 | regulation of MAPK cascade |
| GO:0043279 | 0.01401 | 3.23599 | 2 | 6 | 81 | response to alkaloid |
| GO:1902531 | 0.01404 | 1.39908 | 42 | 56 | 1710 | regulation of intracellular signal transduction |
| GO:1901016 | 0.01419 | 3.74213 | 1 | 5 | 59 | regulation of potassium ion transmembrane transporter activity |
| GO:0034754 | 0.01421 | 2.89151 | 3 | 7 | 105 | cellular hormone metabolic process |
| GO:0055017 | 0.01421 | 2.89151 | 3 | 7 | 105 | cardiac muscle tissue growth |
| GO:1903844 | 0.01421 | 2.89151 | 3 | 7 | 105 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0015850 | 0.01442 | 2.14700 | 6 | 12 | 239 | organic hydroxy compound transport |
| GO:0051899 | 0.01482 | 3.19327 | 2 | 6 | 82 | membrane depolarization |
| GO:0055006 | 0.01490 | 2.86218 | 3 | 7 | 106 | cardiac cell development |
| GO:0001714 | 0.01498 | 13.42823 | 0 | 2 | 8 | endodermal cell fate specification |
| GO:0001993 | 0.01498 | 13.42823 | 0 | 2 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0042435 | 0.01498 | 13.42823 | 0 | 2 | 8 | indole-containing compound biosynthetic process |
| GO:0051581 | 0.01498 | 13.42823 | 0 | 2 | 8 | negative regulation of neurotransmitter uptake |
| GO:0055009 | 0.01498 | 13.42823 | 0 | 2 | 8 | atrial cardiac muscle tissue morphogenesis |
| GO:0070314 | 0.01498 | 13.42823 | 0 | 2 | 8 | G1 to G0 transition |
| GO:0071670 | 0.01498 | 13.42823 | 0 | 2 | 8 | smooth muscle cell chemotaxis |
| GO:1904393 | 0.01498 | 13.42823 | 0 | 2 | 8 | regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:0050808 | 0.01499 | 1.79267 | 11 | 19 | 451 | synapse organization |
| GO:0050982 | 0.01518 | 3.67393 | 1 | 5 | 60 | detection of mechanical stimulus |
| GO:0090183 | 0.01518 | 3.67393 | 1 | 5 | 60 | regulation of kidney development |
| GO:0007269 | 0.01534 | 2.31779 | 4 | 10 | 185 | neurotransmitter secretion |
| GO:0051668 | 0.01534 | 2.31779 | 4 | 10 | 185 | localization within membrane |
| GO:0001841 | 0.01547 | 2.61337 | 3 | 8 | 132 | neural tube formation |
| GO:0002115 | 0.01559 | 6.36842 | 1 | 3 | 22 | store-operated calcium entry |
| GO:0003418 | 0.01559 | 6.36842 | 1 | 3 | 22 | growth plate cartilage chondrocyte differentiation |
| GO:0010996 | 0.01559 | 6.36842 | 1 | 3 | 22 | response to auditory stimulus |
| GO:0014912 | 0.01559 | 6.36842 | 1 | 3 | 22 | negative regulation of smooth muscle cell migration |
| GO:0048857 | 0.01559 | 6.36842 | 1 | 3 | 22 | neural nucleus development |
| GO:0060080 | 0.01559 | 6.36842 | 1 | 3 | 22 | inhibitory postsynaptic potential |
| GO:0070977 | 0.01559 | 6.36842 | 1 | 3 | 22 | bone maturation |
| GO:0099625 | 0.01559 | 6.36842 | 1 | 3 | 22 | ventricular cardiac muscle cell membrane repolarization |
| GO:1902307 | 0.01559 | 6.36842 | 1 | 3 | 22 | positive regulation of sodium ion transmembrane transport |
| GO:0048518 | 0.01574 | 1.22808 | 150 | 173 | 6171 | positive regulation of biological process |
| GO:0007264 | 0.01578 | 1.75372 | 12 | 20 | 485 | small GTPase mediated signal transduction |
| GO:0086004 | 0.01579 | 4.48611 | 1 | 4 | 40 | regulation of cardiac muscle cell contraction |
| GO:0110111 | 0.01579 | 4.48611 | 1 | 4 | 40 | negative regulation of animal organ morphogenesis |
| GO:0006109 | 0.01587 | 2.30452 | 5 | 10 | 186 | regulation of carbohydrate metabolic process |
| GO:0099643 | 0.01587 | 2.30452 | 5 | 10 | 186 | signal release from synapse |
| GO:0046942 | 0.01600 | 1.98306 | 7 | 14 | 301 | carboxylic acid transport |
| GO:0006816 | 0.01605 | 1.81042 | 10 | 18 | 423 | calcium ion transport |
| GO:0046928 | 0.01612 | 2.59235 | 3 | 8 | 133 | regulation of neurotransmitter secretion |
| GO:0040012 | 0.01618 | 1.50417 | 25 | 36 | 1018 | regulation of locomotion |
| GO:0010812 | 0.01621 | 3.60817 | 1 | 5 | 61 | negative regulation of cell-substrate adhesion |
| GO:0006790 | 0.01622 | 2.03933 | 7 | 13 | 272 | sulfur compound metabolic process |
| GO:0003008 | 0.01625 | 1.30145 | 71 | 89 | 2939 | system process |
| GO:0072001 | 0.01642 | 1.97609 | 7 | 14 | 302 | renal system development |
| GO:0060420 | 0.01653 | 3.11111 | 2 | 6 | 84 | regulation of heart growth |
| GO:0002009 | 0.01705 | 1.69050 | 13 | 22 | 553 | morphogenesis of an epithelium |
| GO:0003298 | 0.01717 | 4.36467 | 1 | 4 | 41 | physiological muscle hypertrophy |
| GO:0003301 | 0.01717 | 4.36467 | 1 | 4 | 41 | physiological cardiac muscle hypertrophy |
| GO:0007431 | 0.01717 | 4.36467 | 1 | 4 | 41 | salivary gland development |
| GO:0061049 | 0.01717 | 4.36467 | 1 | 4 | 41 | cell growth involved in cardiac muscle cell development |
| GO:2001258 | 0.01717 | 4.36467 | 1 | 4 | 41 | negative regulation of cation channel activity |
| GO:0007411 | 0.01719 | 2.09116 | 6 | 12 | 245 | axon guidance |
| GO:0003229 | 0.01730 | 3.54471 | 2 | 5 | 62 | ventricular cardiac muscle tissue development |
| GO:0045668 | 0.01730 | 3.54471 | 2 | 5 | 62 | negative regulation of osteoblast differentiation |
| GO:0048008 | 0.01730 | 3.54471 | 2 | 5 | 62 | platelet-derived growth factor receptor signaling pathway |
| GO:0014910 | 0.01743 | 3.07159 | 2 | 6 | 85 | regulation of smooth muscle cell migration |
| GO:0019932 | 0.01748 | 1.79239 | 10 | 18 | 427 | second-messenger-mediated signaling |
| GO:0050794 | 0.01750 | 1.20129 | 262 | 287 | 10774 | regulation of cellular process |
| GO:0051090 | 0.01754 | 1.82593 | 10 | 17 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0042981 | 0.01754 | 1.40540 | 37 | 50 | 1516 | regulation of apoptotic process |
| GO:0000272 | 0.01761 | 6.04973 | 1 | 3 | 23 | polysaccharide catabolic process |
| GO:0097485 | 0.01769 | 2.08213 | 6 | 12 | 246 | neuron projection guidance |
| GO:1901700 | 0.01782 | 1.39485 | 39 | 52 | 1589 | response to oxygen-containing compound |
| GO:0001843 | 0.01794 | 2.75054 | 3 | 7 | 110 | neural tube closure |
| GO:0050803 | 0.01806 | 2.00796 | 7 | 13 | 276 | regulation of synapse structure or activity |
| GO:0016042 | 0.01818 | 1.94867 | 7 | 14 | 306 | lipid catabolic process |
| GO:0050905 | 0.01820 | 2.53125 | 3 | 8 | 136 | neuromuscular process |
| GO:0042490 | 0.01836 | 3.03306 | 2 | 6 | 86 | mechanoreceptor differentiation |
| GO:1904064 | 0.01843 | 2.36841 | 4 | 9 | 163 | positive regulation of cation transmembrane transport |
| GO:0006793 | 0.01846 | 1.29314 | 72 | 89 | 2955 | phosphorus metabolic process |
| GO:0001709 | 0.01863 | 4.24962 | 1 | 4 | 42 | cell fate determination |
| GO:0010518 | 0.01863 | 4.24962 | 1 | 4 | 42 | positive regulation of phospholipase activity |
| GO:0032958 | 0.01863 | 4.24962 | 1 | 4 | 42 | inositol phosphate biosynthetic process |
| GO:0021782 | 0.01876 | 2.72397 | 3 | 7 | 111 | glial cell development |
| GO:0060606 | 0.01876 | 2.72397 | 3 | 7 | 111 | tube closure |
| GO:0030334 | 0.01883 | 1.52376 | 22 | 32 | 892 | regulation of cell migration |
| GO:0001767 | 0.01895 | 11.50941 | 0 | 2 | 9 | establishment of lymphocyte polarity |
| GO:0001768 | 0.01895 | 11.50941 | 0 | 2 | 9 | establishment of T cell polarity |
| GO:0003223 | 0.01895 | 11.50941 | 0 | 2 | 9 | ventricular compact myocardium morphogenesis |
| GO:0003228 | 0.01895 | 11.50941 | 0 | 2 | 9 | atrial cardiac muscle tissue development |
| GO:0006681 | 0.01895 | 11.50941 | 0 | 2 | 9 | galactosylceramide metabolic process |
| GO:0014827 | 0.01895 | 11.50941 | 0 | 2 | 9 | intestine smooth muscle contraction |
| GO:0015886 | 0.01895 | 11.50941 | 0 | 2 | 9 | heme transport |
| GO:0043569 | 0.01895 | 11.50941 | 0 | 2 | 9 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0046877 | 0.01895 | 11.50941 | 0 | 2 | 9 | regulation of saliva secretion |
| GO:0060028 | 0.01895 | 11.50941 | 0 | 2 | 9 | convergent extension involved in axis elongation |
| GO:0060539 | 0.01895 | 11.50941 | 0 | 2 | 9 | diaphragm development |
| GO:0061042 | 0.01895 | 11.50941 | 0 | 2 | 9 | vascular wound healing |
| GO:0090520 | 0.01895 | 11.50941 | 0 | 2 | 9 | sphingolipid mediated signaling pathway |
| GO:0098597 | 0.01895 | 11.50941 | 0 | 2 | 9 | observational learning |
| GO:0099624 | 0.01895 | 11.50941 | 0 | 2 | 9 | atrial cardiac muscle cell membrane repolarization |
| GO:1900125 | 0.01895 | 11.50941 | 0 | 2 | 9 | regulation of hyaluronan biosynthetic process |
| GO:1900454 | 0.01895 | 11.50941 | 0 | 2 | 9 | positive regulation of long-term synaptic depression |
| GO:1902965 | 0.01895 | 11.50941 | 0 | 2 | 9 | regulation of protein localization to early endosome |
| GO:1902966 | 0.01895 | 11.50941 | 0 | 2 | 9 | positive regulation of protein localization to early endosome |
| GO:2000794 | 0.01895 | 11.50941 | 0 | 2 | 9 | regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0048870 | 0.01898 | 1.38903 | 39 | 52 | 1595 | cell motility |
| GO:0051674 | 0.01898 | 1.38903 | 39 | 52 | 1595 | localization of cell |
| GO:0030855 | 0.01955 | 1.62746 | 15 | 24 | 626 | epithelial cell differentiation |
| GO:0000165 | 0.01962 | 1.55252 | 19 | 29 | 793 | MAPK cascade |
| GO:0006706 | 0.01977 | 5.76140 | 1 | 3 | 24 | steroid catabolic process |
| GO:0071392 | 0.01977 | 5.76140 | 1 | 3 | 24 | cellular response to estradiol stimulus |
| GO:0099623 | 0.01977 | 5.76140 | 1 | 3 | 24 | regulation of cardiac muscle cell membrane repolarization |
| GO:1903035 | 0.02034 | 2.95883 | 2 | 6 | 88 | negative regulation of response to wounding |
| GO:2000177 | 0.02048 | 2.67233 | 3 | 7 | 113 | regulation of neural precursor cell proliferation |
| GO:0099173 | 0.02064 | 2.20354 | 5 | 10 | 194 | postsynapse organization |
| GO:0006796 | 0.02085 | 1.28671 | 71 | 88 | 2933 | phosphate-containing compound metabolic process |
| GO:0050878 | 0.02085 | 1.86486 | 8 | 15 | 342 | regulation of body fluid levels |
| GO:0006935 | 0.02089 | 1.63478 | 15 | 23 | 597 | chemotaxis |
| GO:0003002 | 0.02092 | 1.82290 | 9 | 16 | 373 | regionalization |
| GO:0099504 | 0.02097 | 2.10493 | 5 | 11 | 223 | synaptic vesicle cycle |
| GO:0072359 | 0.02114 | 1.44951 | 28 | 39 | 1143 | circulatory system development |
| GO:1901699 | 0.02126 | 1.61369 | 15 | 24 | 631 | cellular response to nitrogen compound |
| GO:0010769 | 0.02133 | 1.85909 | 8 | 15 | 343 | regulation of cell morphogenesis involved in differentiation |
| GO:0031016 | 0.02137 | 2.92305 | 2 | 6 | 89 | pancreas development |
| GO:0060415 | 0.02137 | 2.92305 | 2 | 6 | 89 | muscle tissue morphogenesis |
| GO:0051480 | 0.02138 | 1.81772 | 9 | 16 | 374 | regulation of cytosolic calcium ion concentration |
| GO:0043067 | 0.02195 | 1.38418 | 37 | 50 | 1537 | regulation of programmed cell death |
| GO:0042330 | 0.02198 | 1.62606 | 15 | 23 | 600 | taxis |
| GO:0042430 | 0.02207 | 5.49927 | 1 | 3 | 25 | indole-containing compound metabolic process |
| GO:0060004 | 0.02207 | 5.49927 | 1 | 3 | 25 | reflex |
| GO:0070861 | 0.02207 | 5.49927 | 1 | 3 | 25 | regulation of protein exit from endoplasmic reticulum |
| GO:0086019 | 0.02207 | 5.49927 | 1 | 3 | 25 | cell-cell signaling involved in cardiac conduction |
| GO:0098810 | 0.02207 | 5.49927 | 1 | 3 | 25 | neurotransmitter reuptake |
| GO:1904738 | 0.02207 | 5.49927 | 1 | 3 | 25 | vascular associated smooth muscle cell migration |
| GO:1904752 | 0.02207 | 5.49927 | 1 | 3 | 25 | regulation of vascular associated smooth muscle cell migration |
| GO:0071417 | 0.02230 | 1.64295 | 14 | 22 | 568 | cellular response to organonitrogen compound |
| GO:1901137 | 0.02236 | 1.62318 | 15 | 23 | 601 | carbohydrate derivative biosynthetic process |
| GO:2000145 | 0.02242 | 1.49125 | 23 | 33 | 939 | regulation of cell motility |
| GO:1903524 | 0.02245 | 2.88812 | 2 | 6 | 90 | positive regulation of blood circulation |
| GO:0070838 | 0.02283 | 1.70795 | 11 | 19 | 472 | divalent metal ion transport |
| GO:0001655 | 0.02284 | 1.84199 | 8 | 15 | 346 | urogenital system development |
| GO:0045667 | 0.02292 | 2.41727 | 3 | 8 | 142 | regulation of osteoblast differentiation |
| GO:0055114 | 0.02296 | 1.50798 | 21 | 31 | 872 | oxidation-reduction process |
| GO:0051271 | 0.02321 | 1.88330 | 8 | 14 | 316 | negative regulation of cellular component movement |
| GO:0006874 | 0.02327 | 1.70411 | 11 | 19 | 473 | cellular calcium ion homeostasis |
| GO:0006000 | 0.02331 | 10.07028 | 0 | 2 | 10 | fructose metabolic process |
| GO:0008300 | 0.02331 | 10.07028 | 0 | 2 | 10 | isoprenoid catabolic process |
| GO:0019374 | 0.02331 | 10.07028 | 0 | 2 | 10 | galactolipid metabolic process |
| GO:0021940 | 0.02331 | 10.07028 | 0 | 2 | 10 | positive regulation of cerebellar granule cell precursor proliferation |
| GO:0051124 | 0.02331 | 10.07028 | 0 | 2 | 10 | synaptic growth at neuromuscular junction |
| GO:0097105 | 0.02331 | 10.07028 | 0 | 2 | 10 | presynaptic membrane assembly |
| GO:0099004 | 0.02331 | 10.07028 | 0 | 2 | 10 | calmodulin dependent kinase signaling pathway |
| GO:0051050 | 0.02332 | 1.45273 | 26 | 37 | 1081 | positive regulation of transport |
| GO:0006940 | 0.02341 | 3.25812 | 2 | 5 | 67 | regulation of smooth muscle contraction |
| GO:0050974 | 0.02343 | 3.93815 | 1 | 4 | 45 | detection of mechanical stimulus involved in sensory perception |
| GO:0090184 | 0.02343 | 3.93815 | 1 | 4 | 45 | positive regulation of kidney development |
| GO:0045685 | 0.02356 | 2.85402 | 2 | 6 | 91 | regulation of glial cell differentiation |
| GO:0006629 | 0.02359 | 1.41797 | 31 | 42 | 1258 | lipid metabolic process |
| GO:0019233 | 0.02378 | 2.39925 | 3 | 8 | 143 | sensory perception of pain |
| GO:0030326 | 0.02378 | 2.39925 | 3 | 8 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.02378 | 2.39925 | 3 | 8 | 143 | embryonic appendage morphogenesis |
| GO:0072511 | 0.02416 | 1.69648 | 12 | 19 | 475 | divalent inorganic cation transport |
| GO:0048863 | 0.02420 | 2.05597 | 6 | 11 | 228 | stem cell differentiation |
| GO:0014020 | 0.02424 | 2.57470 | 3 | 7 | 117 | primary neural tube formation |
| GO:0043271 | 0.02427 | 2.25065 | 4 | 9 | 171 | negative regulation of ion transport |
| GO:0001987 | 0.02430 | Inf | 0 | 1 | 1 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure |
| GO:0003061 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of the force of heart contraction by norepinephrine |
| GO:0003359 | 0.02430 | Inf | 0 | 1 | 1 | noradrenergic neuron fate commitment |
| GO:0006867 | 0.02430 | Inf | 0 | 1 | 1 | asparagine transport |
| GO:0007400 | 0.02430 | Inf | 0 | 1 | 1 | neuroblast fate determination |
| GO:0007522 | 0.02430 | Inf | 0 | 1 | 1 | visceral muscle development |
| GO:0010189 | 0.02430 | Inf | 0 | 1 | 1 | vitamin E biosynthetic process |
| GO:0010260 | 0.02430 | Inf | 0 | 1 | 1 | animal organ senescence |
| GO:0014017 | 0.02430 | Inf | 0 | 1 | 1 | neuroblast fate commitment |
| GO:0015774 | 0.02430 | Inf | 0 | 1 | 1 | polysaccharide transport |
| GO:0018146 | 0.02430 | Inf | 0 | 1 | 1 | keratan sulfate biosynthetic process |
| GO:0019285 | 0.02430 | Inf | 0 | 1 | 1 | glycine betaine biosynthetic process from choline |
| GO:0019606 | 0.02430 | Inf | 0 | 1 | 1 | 2-oxobutyrate catabolic process |
| GO:0021509 | 0.02430 | Inf | 0 | 1 | 1 | roof plate formation |
| GO:0021919 | 0.02430 | Inf | 0 | 1 | 1 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning |
| GO:0031455 | 0.02430 | Inf | 0 | 1 | 1 | glycine betaine metabolic process |
| GO:0031456 | 0.02430 | Inf | 0 | 1 | 1 | glycine betaine biosynthetic process |
| GO:0032254 | 0.02430 | Inf | 0 | 1 | 1 | establishment of secretory granule localization |
| GO:0032445 | 0.02430 | Inf | 0 | 1 | 1 | fructose import |
| GO:0032599 | 0.02430 | Inf | 0 | 1 | 1 | protein transport out of membrane raft |
| GO:0032600 | 0.02430 | Inf | 0 | 1 | 1 | chemokine receptor transport out of membrane raft |
| GO:0032913 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of transforming growth factor beta3 production |
| GO:0033606 | 0.02430 | Inf | 0 | 1 | 1 | chemokine receptor transport within lipid bilayer |
| GO:0034102 | 0.02430 | Inf | 0 | 1 | 1 | erythrocyte clearance |
| GO:0034106 | 0.02430 | Inf | 0 | 1 | 1 | regulation of erythrocyte clearance |
| GO:0034107 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte clearance |
| GO:0034119 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte aggregation |
| GO:0034443 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein oxidation |
| GO:0034465 | 0.02430 | Inf | 0 | 1 | 1 | response to carbon monoxide |
| GO:0035565 | 0.02430 | Inf | 0 | 1 | 1 | regulation of pronephros size |
| GO:0035602 | 0.02430 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow |
| GO:0035603 | 0.02430 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in hemopoiesis |
| GO:0035604 | 0.02430 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow |
| GO:0035903 | 0.02430 | Inf | 0 | 1 | 1 | cellular response to immobilization stress |
| GO:0036510 | 0.02430 | Inf | 0 | 1 | 1 | trimming of terminal mannose on C branch |
| GO:0038020 | 0.02430 | Inf | 0 | 1 | 1 | insulin receptor recycling |
| GO:0038133 | 0.02430 | Inf | 0 | 1 | 1 | ERBB2-ERBB3 signaling pathway |
| GO:0042103 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of T cell homeostatic proliferation |
| GO:0042366 | 0.02430 | Inf | 0 | 1 | 1 | cobalamin catabolic process |
| GO:0044324 | 0.02430 | Inf | 0 | 1 | 1 | regulation of transcription involved in anterior/posterior axis specification |
| GO:0044333 | 0.02430 | Inf | 0 | 1 | 1 | Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:0045175 | 0.02430 | Inf | 0 | 1 | 1 | basal protein localization |
| GO:0046014 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of T cell homeostatic proliferation |
| GO:0048698 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of collateral sprouting in absence of injury |
| GO:0050653 | 0.02430 | Inf | 0 | 1 | 1 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
| GO:0051460 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of corticotropin secretion |
| GO:0060082 | 0.02430 | Inf | 0 | 1 | 1 | eye blink reflex |
| GO:0060116 | 0.02430 | Inf | 0 | 1 | 1 | vestibular receptor cell morphogenesis |
| GO:0060165 | 0.02430 | Inf | 0 | 1 | 1 | regulation of timing of subpallium neuron differentiation |
| GO:0060365 | 0.02430 | Inf | 0 | 1 | 1 | coronal suture morphogenesis |
| GO:0060588 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein lipid oxidation |
| GO:0060981 | 0.02430 | Inf | 0 | 1 | 1 | cell migration involved in coronary angiogenesis |
| GO:0061100 | 0.02430 | Inf | 0 | 1 | 1 | lung neuroendocrine cell differentiation |
| GO:0061103 | 0.02430 | Inf | 0 | 1 | 1 | carotid body glomus cell differentiation |
| GO:0061143 | 0.02430 | Inf | 0 | 1 | 1 | alveolar primary septum development |
| GO:0061206 | 0.02430 | Inf | 0 | 1 | 1 | mesonephros morphogenesis |
| GO:0061215 | 0.02430 | Inf | 0 | 1 | 1 | mesonephric nephron development |
| GO:0061228 | 0.02430 | Inf | 0 | 1 | 1 | mesonephric nephron morphogenesis |
| GO:0061235 | 0.02430 | Inf | 0 | 1 | 1 | mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis |
| GO:0061295 | 0.02430 | Inf | 0 | 1 | 1 | regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061296 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061485 | 0.02430 | Inf | 0 | 1 | 1 | memory T cell proliferation |
| GO:0061682 | 0.02430 | Inf | 0 | 1 | 1 | seminal vesicle morphogenesis |
| GO:0061875 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of hepatic stellate cell contraction |
| GO:0070367 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0071911 | 0.02430 | Inf | 0 | 1 | 1 | synchronous neurotransmitter secretion |
| GO:0090242 | 0.02430 | Inf | 0 | 1 | 1 | retinoic acid receptor signaling pathway involved in somitogenesis |
| GO:0098704 | 0.02430 | Inf | 0 | 1 | 1 | carbohydrate import across plasma membrane |
| GO:0098746 | 0.02430 | Inf | 0 | 1 | 1 | fast, calcium ion-dependent exocytosis of neurotransmitter |
| GO:0106096 | 0.02430 | Inf | 0 | 1 | 1 | response to ceramide |
| GO:0140075 | 0.02430 | Inf | 0 | 1 | 1 | regulation of lipoprotein transport |
| GO:0140077 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of lipoprotein transport |
| GO:0140196 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:1900010 | 0.02430 | Inf | 0 | 1 | 1 | regulation of corticotropin-releasing hormone receptor activity |
| GO:1900011 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
| GO:1901146 | 0.02430 | Inf | 0 | 1 | 1 | mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:1901229 | 0.02430 | Inf | 0 | 1 | 1 | regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901231 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901232 | 0.02430 | Inf | 0 | 1 | 1 | regulation of convergent extension involved in axis elongation |
| GO:1901233 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of convergent extension involved in axis elongation |
| GO:1901627 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of postsynaptic membrane organization |
| GO:1901631 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of presynaptic membrane organization |
| GO:1901810 | 0.02430 | Inf | 0 | 1 | 1 | beta-carotene metabolic process |
| GO:1902070 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of sphingolipid mediated signaling pathway |
| GO:1902178 | 0.02430 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor apoptotic signaling pathway |
| GO:1902358 | 0.02430 | Inf | 0 | 1 | 1 | sulfate transmembrane transport |
| GO:1902769 | 0.02430 | Inf | 0 | 1 | 1 | regulation of choline O-acetyltransferase activity |
| GO:1902771 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of choline O-acetyltransferase activity |
| GO:1902955 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of early endosome to recycling endosome transport |
| GO:1902997 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of neurofibrillary tangle assembly |
| GO:1903048 | 0.02430 | Inf | 0 | 1 | 1 | regulation of acetylcholine-gated cation channel activity |
| GO:1903235 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of calcium ion-dependent exocytosis of neurotransmitter |
| GO:1903450 | 0.02430 | Inf | 0 | 1 | 1 | regulation of G1 to G0 transition |
| GO:1903452 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of G1 to G0 transition |
| GO:1903697 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of microvillus assembly |
| GO:1903910 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of receptor clustering |
| GO:1904205 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle hypertrophy |
| GO:1904394 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:1904441 | 0.02430 | Inf | 0 | 1 | 1 | regulation of thyroid gland epithelial cell proliferation |
| GO:1904442 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of thyroid gland epithelial cell proliferation |
| GO:1990539 | 0.02430 | Inf | 0 | 1 | 1 | fructose import across plasma membrane |
| GO:1990789 | 0.02430 | Inf | 0 | 1 | 1 | thyroid gland epithelial cell proliferation |
| GO:1990790 | 0.02430 | Inf | 0 | 1 | 1 | response to glial cell derived neurotrophic factor |
| GO:1990792 | 0.02430 | Inf | 0 | 1 | 1 | cellular response to glial cell derived neurotrophic factor |
| GO:2000056 | 0.02430 | Inf | 0 | 1 | 1 | regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000057 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000487 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of glutamine transport |
| GO:2000577 | 0.02430 | Inf | 0 | 1 | 1 | regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000578 | 0.02430 | Inf | 0 | 1 | 1 | negative regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2001049 | 0.02430 | Inf | 0 | 1 | 1 | regulation of tendon cell differentiation |
| GO:2001051 | 0.02430 | Inf | 0 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0007263 | 0.02451 | 5.25994 | 1 | 3 | 26 | nitric oxide mediated signal transduction |
| GO:0033688 | 0.02451 | 5.25994 | 1 | 3 | 26 | regulation of osteoblast proliferation |
| GO:0045761 | 0.02451 | 5.25994 | 1 | 3 | 26 | regulation of adenylate cyclase activity |
| GO:0051125 | 0.02451 | 5.25994 | 1 | 3 | 26 | regulation of actin nucleation |
| GO:0051497 | 0.02451 | 5.25994 | 1 | 3 | 26 | negative regulation of stress fiber assembly |
| GO:0060065 | 0.02451 | 5.25994 | 1 | 3 | 26 | uterus development |
| GO:0089718 | 0.02451 | 5.25994 | 1 | 3 | 26 | amino acid import across plasma membrane |
| GO:0090189 | 0.02451 | 5.25994 | 1 | 3 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:2000050 | 0.02451 | 5.25994 | 1 | 3 | 26 | regulation of non-canonical Wnt signaling pathway |
| GO:0007613 | 0.02466 | 2.38151 | 3 | 8 | 144 | memory |
| GO:0014909 | 0.02470 | 2.82071 | 2 | 6 | 92 | smooth muscle cell migration |
| GO:0006855 | 0.02478 | 3.20626 | 2 | 5 | 68 | drug transmembrane transport |
| GO:0034109 | 0.02478 | 3.20626 | 2 | 5 | 68 | homotypic cell-cell adhesion |
| GO:0008217 | 0.02485 | 2.13338 | 5 | 10 | 200 | regulation of blood pressure |
| GO:0018108 | 0.02490 | 1.86452 | 8 | 14 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0071230 | 0.02508 | 2.23674 | 4 | 9 | 172 | cellular response to amino acid stimulus |
| GO:0023014 | 0.02510 | 1.51755 | 20 | 29 | 810 | signal transduction by protein phosphorylation |
| GO:0001941 | 0.02518 | 3.84422 | 1 | 4 | 46 | postsynaptic membrane organization |
| GO:0010677 | 0.02518 | 3.84422 | 1 | 4 | 46 | negative regulation of cellular carbohydrate metabolic process |
| GO:0042476 | 0.02525 | 2.55139 | 3 | 7 | 118 | odontogenesis |
| GO:0050801 | 0.02582 | 1.51353 | 20 | 29 | 812 | ion homeostasis |
| GO:0051260 | 0.02593 | 1.77243 | 9 | 16 | 383 | protein homooligomerization |
| GO:0007405 | 0.02620 | 3.15603 | 2 | 5 | 69 | neuroblast proliferation |
| GO:0051963 | 0.02629 | 2.52850 | 3 | 7 | 119 | regulation of synapse assembly |
| GO:0098771 | 0.02662 | 1.53334 | 18 | 27 | 746 | inorganic ion homeostasis |
| GO:0018212 | 0.02668 | 1.84612 | 8 | 14 | 322 | peptidyl-tyrosine modification |
| GO:0001990 | 0.02701 | 3.75465 | 1 | 4 | 47 | regulation of systemic arterial blood pressure by hormone |
| GO:0120163 | 0.02701 | 3.75465 | 1 | 4 | 47 | negative regulation of cold-induced thermogenesis |
| GO:0014829 | 0.02708 | 5.04055 | 1 | 3 | 27 | vascular smooth muscle contraction |
| GO:0048745 | 0.02708 | 5.04055 | 1 | 3 | 27 | smooth muscle tissue development |
| GO:0061298 | 0.02708 | 5.04055 | 1 | 3 | 27 | retina vasculature development in camera-type eye |
| GO:0060021 | 0.02710 | 2.75635 | 2 | 6 | 94 | roof of mouth development |
| GO:0042063 | 0.02730 | 1.84006 | 8 | 14 | 323 | gliogenesis |
| GO:0006081 | 0.02768 | 3.10733 | 2 | 5 | 70 | cellular aldehyde metabolic process |
| GO:0046173 | 0.02768 | 3.10733 | 2 | 5 | 70 | polyol biosynthetic process |
| GO:0097435 | 0.02768 | 1.55479 | 17 | 25 | 681 | supramolecular fiber organization |
| GO:0007187 | 0.02779 | 2.00922 | 6 | 11 | 233 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0007188 | 0.02798 | 2.08902 | 5 | 10 | 204 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0031032 | 0.02798 | 2.08902 | 5 | 10 | 204 | actomyosin structure organization |
| GO:0071560 | 0.02798 | 2.08902 | 5 | 10 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:0002118 | 0.02804 | 8.95097 | 0 | 2 | 11 | aggressive behavior |
| GO:0006002 | 0.02804 | 8.95097 | 0 | 2 | 11 | fructose 6-phosphate metabolic process |
| GO:0009111 | 0.02804 | 8.95097 | 0 | 2 | 11 | vitamin catabolic process |
| GO:0014824 | 0.02804 | 8.95097 | 0 | 2 | 11 | artery smooth muscle contraction |
| GO:0019227 | 0.02804 | 8.95097 | 0 | 2 | 11 | neuronal action potential propagation |
| GO:0021559 | 0.02804 | 8.95097 | 0 | 2 | 11 | trigeminal nerve development |
| GO:0033603 | 0.02804 | 8.95097 | 0 | 2 | 11 | positive regulation of dopamine secretion |
| GO:0035733 | 0.02804 | 8.95097 | 0 | 2 | 11 | hepatic stellate cell activation |
| GO:0060174 | 0.02804 | 8.95097 | 0 | 2 | 11 | limb bud formation |
| GO:0060900 | 0.02804 | 8.95097 | 0 | 2 | 11 | embryonic camera-type eye formation |
| GO:0061299 | 0.02804 | 8.95097 | 0 | 2 | 11 | retina vasculature morphogenesis in camera-type eye |
| GO:0061669 | 0.02804 | 8.95097 | 0 | 2 | 11 | spontaneous neurotransmitter secretion |
| GO:0071864 | 0.02804 | 8.95097 | 0 | 2 | 11 | positive regulation of cell proliferation in bone marrow |
| GO:0072102 | 0.02804 | 8.95097 | 0 | 2 | 11 | glomerulus morphogenesis |
| GO:0072172 | 0.02804 | 8.95097 | 0 | 2 | 11 | mesonephric tubule formation |
| GO:0098870 | 0.02804 | 8.95097 | 0 | 2 | 11 | action potential propagation |
| GO:1901678 | 0.02804 | 8.95097 | 0 | 2 | 11 | iron coordination entity transport |
| GO:1902260 | 0.02804 | 8.95097 | 0 | 2 | 11 | negative regulation of delayed rectifier potassium channel activity |
| GO:0051128 | 0.02807 | 1.28509 | 62 | 77 | 2558 | regulation of cellular component organization |
| GO:0003231 | 0.02844 | 2.31305 | 4 | 8 | 148 | cardiac ventricle development |
| GO:0007157 | 0.02892 | 3.66916 | 1 | 4 | 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0050850 | 0.02892 | 3.66916 | 1 | 4 | 48 | positive regulation of calcium-mediated signaling |
| GO:0032413 | 0.02920 | 3.06012 | 2 | 5 | 71 | negative regulation of ion transmembrane transporter activity |
| GO:0050433 | 0.02920 | 3.06012 | 2 | 5 | 71 | regulation of catecholamine secretion |
| GO:0043410 | 0.02973 | 1.63172 | 13 | 20 | 519 | positive regulation of MAPK cascade |
| GO:0051589 | 0.02980 | 4.83872 | 1 | 3 | 28 | negative regulation of neurotransmitter transport |
| GO:0060445 | 0.02980 | 4.83872 | 1 | 3 | 28 | branching involved in salivary gland morphogenesis |
| GO:0061217 | 0.02980 | 4.83872 | 1 | 3 | 28 | regulation of mesonephros development |
| GO:0098698 | 0.02980 | 4.83872 | 1 | 3 | 28 | postsynaptic specialization assembly |
| GO:0043009 | 0.03046 | 1.48987 | 20 | 29 | 824 | chordate embryonic development |
| GO:0014013 | 0.03046 | 2.28027 | 4 | 8 | 150 | regulation of gliogenesis |
| GO:0022612 | 0.03046 | 2.28027 | 4 | 8 | 150 | gland morphogenesis |
| GO:0048645 | 0.03077 | 3.01431 | 2 | 5 | 72 | animal organ formation |
| GO:0032941 | 0.03091 | 3.58746 | 1 | 4 | 49 | secretion by tissue |
| GO:0048644 | 0.03099 | 2.66513 | 2 | 6 | 97 | muscle organ morphogenesis |
| GO:0055074 | 0.03121 | 1.64491 | 12 | 19 | 489 | calcium ion homeostasis |
| GO:0034767 | 0.03131 | 2.14397 | 4 | 9 | 179 | positive regulation of ion transmembrane transport |
| GO:1901861 | 0.03131 | 2.14397 | 4 | 9 | 179 | regulation of muscle tissue development |
| GO:0071559 | 0.03137 | 2.04646 | 5 | 10 | 208 | response to transforming growth factor beta |
| GO:0048167 | 0.03162 | 1.76095 | 9 | 15 | 361 | regulation of synaptic plasticity |
| GO:0030336 | 0.03164 | 1.90132 | 7 | 12 | 268 | negative regulation of cell migration |
| GO:0006915 | 0.03190 | 1.32030 | 45 | 58 | 1867 | apoptotic process |
| GO:0019722 | 0.03227 | 2.03608 | 5 | 10 | 209 | calcium-mediated signaling |
| GO:0007416 | 0.03228 | 2.13134 | 4 | 9 | 180 | synapse assembly |
| GO:0048634 | 0.03228 | 2.13134 | 4 | 9 | 180 | regulation of muscle organ development |
| GO:0007422 | 0.03240 | 2.96985 | 2 | 5 | 73 | peripheral nervous system development |
| GO:0051145 | 0.03240 | 2.96985 | 2 | 5 | 73 | smooth muscle cell differentiation |
| GO:0051155 | 0.03240 | 2.96985 | 2 | 5 | 73 | positive regulation of striated muscle cell differentiation |
| GO:0010675 | 0.03259 | 2.24840 | 4 | 8 | 152 | regulation of cellular carbohydrate metabolic process |
| GO:0033687 | 0.03266 | 4.65241 | 1 | 3 | 29 | osteoblast proliferation |
| GO:0043090 | 0.03266 | 4.65241 | 1 | 3 | 29 | amino acid import |
| GO:0060571 | 0.03266 | 4.65241 | 1 | 3 | 29 | morphogenesis of an epithelial fold |
| GO:0099622 | 0.03266 | 4.65241 | 1 | 3 | 29 | cardiac muscle cell membrane repolarization |
| GO:0099054 | 0.03297 | 3.50932 | 1 | 4 | 50 | presynapse assembly |
| GO:1900047 | 0.03297 | 3.50932 | 1 | 4 | 50 | negative regulation of hemostasis |
| GO:0012501 | 0.03309 | 1.31409 | 46 | 59 | 1908 | programmed cell death |
| GO:0006098 | 0.03311 | 8.05552 | 0 | 2 | 12 | pentose-phosphate shunt |
| GO:0007168 | 0.03311 | 8.05552 | 0 | 2 | 12 | receptor guanylyl cyclase signaling pathway |
| GO:0030388 | 0.03311 | 8.05552 | 0 | 2 | 12 | fructose 1,6-bisphosphate metabolic process |
| GO:0030432 | 0.03311 | 8.05552 | 0 | 2 | 12 | peristalsis |
| GO:0043471 | 0.03311 | 8.05552 | 0 | 2 | 12 | regulation of cellular carbohydrate catabolic process |
| GO:0045161 | 0.03311 | 8.05552 | 0 | 2 | 12 | neuronal ion channel clustering |
| GO:0060502 | 0.03311 | 8.05552 | 0 | 2 | 12 | epithelial cell proliferation involved in lung morphogenesis |
| GO:0070444 | 0.03311 | 8.05552 | 0 | 2 | 12 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.03311 | 8.05552 | 0 | 2 | 12 | regulation of oligodendrocyte progenitor proliferation |
| GO:0071863 | 0.03311 | 8.05552 | 0 | 2 | 12 | regulation of cell proliferation in bone marrow |
| GO:0086013 | 0.03311 | 8.05552 | 0 | 2 | 12 | membrane repolarization during cardiac muscle cell action potential |
| GO:0090494 | 0.03311 | 8.05552 | 0 | 2 | 12 | dopamine uptake |
| GO:1900272 | 0.03311 | 8.05552 | 0 | 2 | 12 | negative regulation of long-term synaptic potentiation |
| GO:1902946 | 0.03311 | 8.05552 | 0 | 2 | 12 | protein localization to early endosome |
| GO:1905668 | 0.03311 | 8.05552 | 0 | 2 | 12 | positive regulation of protein localization to endosome |
| GO:2000402 | 0.03311 | 8.05552 | 0 | 2 | 12 | negative regulation of lymphocyte migration |
| GO:0098656 | 0.03327 | 2.11886 | 4 | 9 | 181 | anion transmembrane transport |
| GO:0040013 | 0.03331 | 1.78726 | 8 | 14 | 332 | negative regulation of locomotion |
| GO:1903530 | 0.03345 | 1.47639 | 20 | 29 | 831 | regulation of secretion by cell |
| GO:0033865 | 0.03377 | 2.60758 | 2 | 6 | 99 | nucleoside bisphosphate metabolic process |
| GO:0033875 | 0.03377 | 2.60758 | 2 | 6 | 99 | ribonucleoside bisphosphate metabolic process |
| GO:0034032 | 0.03377 | 2.60758 | 2 | 6 | 99 | purine nucleoside bisphosphate metabolic process |
| GO:0050432 | 0.03408 | 2.92668 | 2 | 5 | 74 | catecholamine secretion |
| GO:0019220 | 0.03449 | 1.32935 | 41 | 53 | 1692 | regulation of phosphate metabolic process |
| GO:0051174 | 0.03481 | 1.32848 | 41 | 53 | 1693 | regulation of phosphorus metabolic process |
| GO:0035264 | 0.03505 | 2.00558 | 5 | 10 | 212 | multicellular organism growth |
| GO:0030901 | 0.03512 | 3.43450 | 1 | 4 | 51 | midbrain development |
| GO:0031018 | 0.03512 | 3.43450 | 1 | 4 | 51 | endocrine pancreas development |
| GO:0048806 | 0.03512 | 3.43450 | 1 | 4 | 51 | genitalia development |
| GO:0051954 | 0.03512 | 3.43450 | 1 | 4 | 51 | positive regulation of amine transport |
| GO:0060359 | 0.03522 | 2.57973 | 2 | 6 | 100 | response to ammonium ion |
| GO:0061351 | 0.03531 | 2.09432 | 4 | 9 | 183 | neural precursor cell proliferation |
| GO:0035239 | 0.03544 | 1.44884 | 22 | 31 | 905 | tube morphogenesis |
| GO:0055080 | 0.03547 | 1.50184 | 18 | 26 | 732 | cation homeostasis |
| GO:0055065 | 0.03559 | 1.52819 | 16 | 24 | 664 | metal ion homeostasis |
| GO:0015012 | 0.03565 | 4.47990 | 1 | 3 | 30 | heparan sulfate proteoglycan biosynthetic process |
| GO:0022011 | 0.03565 | 4.47990 | 1 | 3 | 30 | myelination in peripheral nervous system |
| GO:0032292 | 0.03565 | 4.47990 | 1 | 3 | 30 | peripheral nervous system axon ensheathment |
| GO:0072503 | 0.03587 | 1.61680 | 12 | 19 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0003300 | 0.03671 | 2.55246 | 2 | 6 | 101 | cardiac muscle hypertrophy |
| GO:0042310 | 0.03671 | 2.55246 | 2 | 6 | 101 | vasoconstriction |
| GO:0055024 | 0.03671 | 2.55246 | 2 | 6 | 101 | regulation of cardiac muscle tissue development |
| GO:2000300 | 0.03671 | 2.55246 | 2 | 6 | 101 | regulation of synaptic vesicle exocytosis |
| GO:0017157 | 0.03699 | 1.91343 | 6 | 11 | 244 | regulation of exocytosis |
| GO:1990845 | 0.03713 | 2.18724 | 4 | 8 | 156 | adaptive thermogenesis |
| GO:0032101 | 0.03727 | 1.48219 | 19 | 27 | 770 | regulation of response to external stimulus |
| GO:1900271 | 0.03734 | 3.36280 | 1 | 4 | 52 | regulation of long-term synaptic potentiation |
| GO:0043200 | 0.03744 | 2.07033 | 4 | 9 | 185 | response to amino acid |
| GO:0030168 | 0.03760 | 2.84399 | 2 | 5 | 76 | platelet activation |
| GO:0055008 | 0.03760 | 2.84399 | 2 | 5 | 76 | cardiac muscle tissue morphogenesis |
| GO:0048732 | 0.03772 | 1.62978 | 11 | 18 | 467 | gland development |
| GO:0009792 | 0.03810 | 1.45754 | 20 | 29 | 841 | embryo development ending in birth or egg hatching |
| GO:0051046 | 0.03817 | 1.43857 | 22 | 31 | 911 | regulation of secretion |
| GO:0021510 | 0.03823 | 2.52576 | 2 | 6 | 102 | spinal cord development |
| GO:0045995 | 0.03831 | 2.32022 | 3 | 7 | 129 | regulation of embryonic development |
| GO:0010755 | 0.03851 | 7.32287 | 0 | 2 | 13 | regulation of plasminogen activation |
| GO:0014820 | 0.03851 | 7.32287 | 0 | 2 | 13 | tonic smooth muscle contraction |
| GO:0015802 | 0.03851 | 7.32287 | 0 | 2 | 13 | basic amino acid transport |
| GO:0021936 | 0.03851 | 7.32287 | 0 | 2 | 13 | regulation of cerebellar granule cell precursor proliferation |
| GO:0045820 | 0.03851 | 7.32287 | 0 | 2 | 13 | negative regulation of glycolytic process |
| GO:0060272 | 0.03851 | 7.32287 | 0 | 2 | 13 | embryonic skeletal joint morphogenesis |
| GO:0060601 | 0.03851 | 7.32287 | 0 | 2 | 13 | lateral sprouting from an epithelium |
| GO:0060670 | 0.03851 | 7.32287 | 0 | 2 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0072110 | 0.03851 | 7.32287 | 0 | 2 | 13 | glomerular mesangial cell proliferation |
| GO:0090193 | 0.03851 | 7.32287 | 0 | 2 | 13 | positive regulation of glomerulus development |
| GO:0090493 | 0.03851 | 7.32287 | 0 | 2 | 13 | catecholamine uptake |
| GO:1903025 | 0.03851 | 7.32287 | 0 | 2 | 13 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1903817 | 0.03851 | 7.32287 | 0 | 2 | 13 | negative regulation of voltage-gated potassium channel activity |
| GO:1905048 | 0.03851 | 7.32287 | 0 | 2 | 13 | regulation of metallopeptidase activity |
| GO:1905666 | 0.03851 | 7.32287 | 0 | 2 | 13 | regulation of protein localization to endosome |
| GO:0032232 | 0.03878 | 4.31971 | 1 | 3 | 31 | negative regulation of actin filament bundle assembly |
| GO:0043537 | 0.03878 | 4.31971 | 1 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0045662 | 0.03878 | 4.31971 | 1 | 3 | 31 | negative regulation of myoblast differentiation |
| GO:0099560 | 0.03878 | 4.31971 | 1 | 3 | 31 | synaptic membrane adhesion |
| GO:1901020 | 0.03878 | 4.31971 | 1 | 3 | 31 | negative regulation of calcium ion transmembrane transporter activity |
| GO:2001014 | 0.03878 | 4.31971 | 1 | 3 | 31 | regulation of skeletal muscle cell differentiation |
| GO:0010975 | 0.03936 | 1.54153 | 15 | 22 | 603 | regulation of neuron projection development |
| GO:0055021 | 0.03945 | 2.80436 | 2 | 5 | 77 | regulation of cardiac muscle tissue growth |
| GO:0009948 | 0.03964 | 3.29402 | 1 | 4 | 53 | anterior/posterior axis specification |
| GO:0010517 | 0.03964 | 3.29402 | 1 | 4 | 53 | regulation of phospholipase activity |
| GO:0014014 | 0.03964 | 3.29402 | 1 | 4 | 53 | negative regulation of gliogenesis |
| GO:0045933 | 0.03964 | 3.29402 | 1 | 4 | 53 | positive regulation of muscle contraction |
| GO:0030534 | 0.03966 | 2.04689 | 5 | 9 | 187 | adult behavior |
| GO:0097479 | 0.03966 | 2.04689 | 5 | 9 | 187 | synaptic vesicle localization |
| GO:0009953 | 0.03980 | 2.49961 | 3 | 6 | 103 | dorsal/ventral pattern formation |
| GO:0055082 | 0.04001 | 1.46055 | 20 | 28 | 810 | cellular chemical homeostasis |
| GO:0009101 | 0.04007 | 1.82903 | 7 | 12 | 278 | glycoprotein biosynthetic process |
| GO:0070374 | 0.04112 | 1.94720 | 5 | 10 | 218 | positive regulation of ERK1 and ERK2 cascade |
| GO:1900046 | 0.04134 | 2.76582 | 2 | 5 | 78 | regulation of hemostasis |
| GO:1901862 | 0.04134 | 2.76582 | 2 | 5 | 78 | negative regulation of muscle tissue development |
| GO:0044264 | 0.04141 | 2.47400 | 3 | 6 | 104 | cellular polysaccharide metabolic process |
| GO:0030003 | 0.04179 | 1.51536 | 16 | 23 | 641 | cellular cation homeostasis |
| GO:0006887 | 0.04184 | 1.69141 | 9 | 15 | 375 | exocytosis |
| GO:0035272 | 0.04202 | 3.22800 | 1 | 4 | 54 | exocrine system development |
| GO:0044060 | 0.04202 | 3.22800 | 1 | 4 | 54 | regulation of endocrine process |
| GO:0055025 | 0.04202 | 3.22800 | 1 | 4 | 54 | positive regulation of cardiac muscle tissue development |
| GO:0060193 | 0.04202 | 3.22800 | 1 | 4 | 54 | positive regulation of lipase activity |
| GO:0007274 | 0.04204 | 4.17057 | 1 | 3 | 32 | neuromuscular synaptic transmission |
| GO:0040036 | 0.04204 | 4.17057 | 1 | 3 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0060306 | 0.04204 | 4.17057 | 1 | 3 | 32 | regulation of membrane repolarization |
| GO:0060669 | 0.04204 | 4.17057 | 1 | 3 | 32 | embryonic placenta morphogenesis |
| GO:0060977 | 0.04204 | 4.17057 | 1 | 3 | 32 | coronary vasculature morphogenesis |
| GO:0045597 | 0.04239 | 1.38709 | 27 | 36 | 1097 | positive regulation of cell differentiation |
| GO:0032956 | 0.04274 | 1.72134 | 8 | 14 | 344 | regulation of actin cytoskeleton organization |
| GO:0001822 | 0.04288 | 1.80839 | 7 | 12 | 281 | kidney development |
| GO:2000146 | 0.04288 | 1.80839 | 7 | 12 | 281 | negative regulation of cell motility |
| GO:0003208 | 0.04329 | 2.72833 | 2 | 5 | 79 | cardiac ventricle morphogenesis |
| GO:0032890 | 0.04329 | 2.72833 | 2 | 5 | 79 | regulation of organic acid transport |
| GO:0044272 | 0.04329 | 2.72833 | 2 | 5 | 79 | sulfur compound biosynthetic process |
| GO:0010642 | 0.04422 | 6.71234 | 0 | 2 | 14 | negative regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010896 | 0.04422 | 6.71234 | 0 | 2 | 14 | regulation of triglyceride catabolic process |
| GO:0014831 | 0.04422 | 6.71234 | 0 | 2 | 14 | gastro-intestinal system smooth muscle contraction |
| GO:0021527 | 0.04422 | 6.71234 | 0 | 2 | 14 | spinal cord association neuron differentiation |
| GO:0030213 | 0.04422 | 6.71234 | 0 | 2 | 14 | hyaluronan biosynthetic process |
| GO:0030812 | 0.04422 | 6.71234 | 0 | 2 | 14 | negative regulation of nucleotide catabolic process |
| GO:0033690 | 0.04422 | 6.71234 | 0 | 2 | 14 | positive regulation of osteoblast proliferation |
| GO:0035791 | 0.04422 | 6.71234 | 0 | 2 | 14 | platelet-derived growth factor receptor-beta signaling pathway |
| GO:0042574 | 0.04422 | 6.71234 | 0 | 2 | 14 | retinal metabolic process |
| GO:0051198 | 0.04422 | 6.71234 | 0 | 2 | 14 | negative regulation of coenzyme metabolic process |
| GO:0060732 | 0.04422 | 6.71234 | 0 | 2 | 14 | positive regulation of inositol phosphate biosynthetic process |
| GO:0072537 | 0.04422 | 6.71234 | 0 | 2 | 14 | fibroblast activation |
| GO:0090179 | 0.04422 | 6.71234 | 0 | 2 | 14 | planar cell polarity pathway involved in neural tube closure |
| GO:0098719 | 0.04422 | 6.71234 | 0 | 2 | 14 | sodium ion import across plasma membrane |
| GO:0098814 | 0.04422 | 6.71234 | 0 | 2 | 14 | spontaneous synaptic transmission |
| GO:0099151 | 0.04422 | 6.71234 | 0 | 2 | 14 | regulation of postsynaptic density assembly |
| GO:0021915 | 0.04435 | 2.00154 | 5 | 9 | 191 | neural tube development |
| GO:0009628 | 0.04447 | 1.39445 | 25 | 34 | 1030 | response to abiotic stimulus |
| GO:0007528 | 0.04448 | 3.16457 | 1 | 4 | 55 | neuromuscular junction development |
| GO:0035019 | 0.04448 | 3.16457 | 1 | 4 | 55 | somatic stem cell population maintenance |
| GO:0043470 | 0.04448 | 3.16457 | 1 | 4 | 55 | regulation of carbohydrate catabolic process |
| GO:0046513 | 0.04448 | 3.16457 | 1 | 4 | 55 | ceramide biosynthetic process |
| GO:0014812 | 0.04475 | 2.42430 | 3 | 6 | 106 | muscle cell migration |
| GO:0022600 | 0.04475 | 2.42430 | 3 | 6 | 106 | digestive system process |
| GO:0048661 | 0.04475 | 2.42430 | 3 | 6 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0060840 | 0.04475 | 2.42430 | 3 | 6 | 106 | artery development |
| GO:1902803 | 0.04475 | 2.42430 | 3 | 6 | 106 | regulation of synaptic vesicle transport |
| GO:0010941 | 0.04506 | 1.30688 | 41 | 52 | 1685 | regulation of cell death |
| GO:0021675 | 0.04529 | 2.69183 | 2 | 5 | 80 | nerve development |
| GO:0060113 | 0.04529 | 2.69183 | 2 | 5 | 80 | inner ear receptor cell differentiation |
| GO:0014044 | 0.04543 | 4.03137 | 1 | 3 | 33 | Schwann cell development |
| GO:0060740 | 0.04543 | 4.03137 | 1 | 3 | 33 | prostate gland epithelium morphogenesis |
| GO:1905606 | 0.04543 | 4.03137 | 1 | 3 | 33 | regulation of presynapse assembly |
| GO:0060562 | 0.04600 | 1.66786 | 9 | 15 | 380 | epithelial tube morphogenesis |
| GO:0010563 | 0.04622 | 1.54607 | 13 | 20 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.04622 | 1.54607 | 13 | 20 | 546 | negative regulation of phosphate metabolic process |
| GO:0003014 | 0.04648 | 2.40019 | 3 | 6 | 107 | renal system process |
| GO:0097756 | 0.04648 | 2.40019 | 3 | 6 | 107 | negative regulation of blood vessel diameter |
| GO:0055002 | 0.04683 | 1.97961 | 5 | 9 | 193 | striated muscle cell development |
| GO:0042596 | 0.04702 | 3.10357 | 1 | 4 | 56 | fear response |
| GO:0030902 | 0.04746 | 2.07434 | 4 | 8 | 164 | hindbrain development |
| GO:0006875 | 0.04774 | 1.52249 | 14 | 21 | 582 | cellular metal ion homeostasis |
| GO:1901615 | 0.04780 | 1.57950 | 12 | 18 | 481 | organic hydroxy compound metabolic process |
| GO:0019725 | 0.04791 | 1.40694 | 23 | 31 | 930 | cellular homeostasis |
| GO:0015711 | 0.04799 | 1.62794 | 10 | 16 | 415 | organic anion transport |
| GO:0001982 | 0.04801 | 40.22202 | 0 | 1 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
| GO:0002842 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of T cell mediated immune response to tumor cell |
| GO:0003050 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
| GO:0006713 | 0.04801 | 40.22202 | 0 | 1 | 2 | glucocorticoid catabolic process |
| GO:0009758 | 0.04801 | 40.22202 | 0 | 1 | 2 | carbohydrate utilization |
| GO:0010142 | 0.04801 | 40.22202 | 0 | 1 | 2 | farnesyl diphosphate biosynthetic process, mevalonate pathway |
| GO:0010848 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of chromatin disassembly |
| GO:0015817 | 0.04801 | 40.22202 | 0 | 1 | 2 | histidine transport |
| GO:0016119 | 0.04801 | 40.22202 | 0 | 1 | 2 | carotene metabolic process |
| GO:0016121 | 0.04801 | 40.22202 | 0 | 1 | 2 | carotene catabolic process |
| GO:0016332 | 0.04801 | 40.22202 | 0 | 1 | 2 | establishment or maintenance of polarity of embryonic epithelium |
| GO:0016598 | 0.04801 | 40.22202 | 0 | 1 | 2 | protein arginylation |
| GO:0021730 | 0.04801 | 40.22202 | 0 | 1 | 2 | trigeminal sensory nucleus development |
| GO:0021740 | 0.04801 | 40.22202 | 0 | 1 | 2 | principal sensory nucleus of trigeminal nerve development |
| GO:0021750 | 0.04801 | 40.22202 | 0 | 1 | 2 | vestibular nucleus development |
| GO:0021762 | 0.04801 | 40.22202 | 0 | 1 | 2 | substantia nigra development |
| GO:0021769 | 0.04801 | 40.22202 | 0 | 1 | 2 | orbitofrontal cortex development |
| GO:0032902 | 0.04801 | 40.22202 | 0 | 1 | 2 | nerve growth factor production |
| GO:0033037 | 0.04801 | 40.22202 | 0 | 1 | 2 | polysaccharide localization |
| GO:0034036 | 0.04801 | 40.22202 | 0 | 1 | 2 | purine ribonucleoside bisphosphate biosynthetic process |
| GO:0034117 | 0.04801 | 40.22202 | 0 | 1 | 2 | erythrocyte aggregation |
| GO:0034118 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of erythrocyte aggregation |
| GO:0034146 | 0.04801 | 40.22202 | 0 | 1 | 2 | toll-like receptor 5 signaling pathway |
| GO:0034439 | 0.04801 | 40.22202 | 0 | 1 | 2 | lipoprotein lipid oxidation |
| GO:0034442 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of lipoprotein oxidation |
| GO:0035408 | 0.04801 | 40.22202 | 0 | 1 | 2 | histone H3-T6 phosphorylation |
| GO:0035607 | 0.04801 | 40.22202 | 0 | 1 | 2 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development |
| GO:0035981 | 0.04801 | 40.22202 | 0 | 1 | 2 | tongue muscle cell differentiation |
| GO:0036413 | 0.04801 | 40.22202 | 0 | 1 | 2 | histone H3-R26 citrullination |
| GO:0038129 | 0.04801 | 40.22202 | 0 | 1 | 2 | ERBB3 signaling pathway |
| GO:0039020 | 0.04801 | 40.22202 | 0 | 1 | 2 | pronephric nephron tubule development |
| GO:0042160 | 0.04801 | 40.22202 | 0 | 1 | 2 | lipoprotein modification |
| GO:0042161 | 0.04801 | 40.22202 | 0 | 1 | 2 | lipoprotein oxidation |
| GO:0042214 | 0.04801 | 40.22202 | 0 | 1 | 2 | terpene metabolic process |
| GO:0042339 | 0.04801 | 40.22202 | 0 | 1 | 2 | keratan sulfate metabolic process |
| GO:0042365 | 0.04801 | 40.22202 | 0 | 1 | 2 | water-soluble vitamin catabolic process |
| GO:0042371 | 0.04801 | 40.22202 | 0 | 1 | 2 | vitamin K biosynthetic process |
| GO:0042664 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of endodermal cell fate specification |
| GO:0043585 | 0.04801 | 40.22202 | 0 | 1 | 2 | nose morphogenesis |
| GO:0043932 | 0.04801 | 40.22202 | 0 | 1 | 2 | ossification involved in bone remodeling |
| GO:0045818 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of glycogen catabolic process |
| GO:0045819 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of glycogen catabolic process |
| GO:0046247 | 0.04801 | 40.22202 | 0 | 1 | 2 | terpene catabolic process |
| GO:0046361 | 0.04801 | 40.22202 | 0 | 1 | 2 | 2-oxobutyrate metabolic process |
| GO:0046398 | 0.04801 | 40.22202 | 0 | 1 | 2 | UDP-glucuronate metabolic process |
| GO:0048749 | 0.04801 | 40.22202 | 0 | 1 | 2 | compound eye development |
| GO:0048867 | 0.04801 | 40.22202 | 0 | 1 | 2 | stem cell fate determination |
| GO:0050428 | 0.04801 | 40.22202 | 0 | 1 | 2 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process |
| GO:0060032 | 0.04801 | 40.22202 | 0 | 1 | 2 | notochord regression |
| GO:0060114 | 0.04801 | 40.22202 | 0 | 1 | 2 | vestibular receptor cell differentiation |
| GO:0060118 | 0.04801 | 40.22202 | 0 | 1 | 2 | vestibular receptor cell development |
| GO:0060163 | 0.04801 | 40.22202 | 0 | 1 | 2 | subpallium neuron fate commitment |
| GO:0060302 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of cytokine activity |
| GO:0060529 | 0.04801 | 40.22202 | 0 | 1 | 2 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development |
| GO:0060587 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of lipoprotein lipid oxidation |
| GO:0060595 | 0.04801 | 40.22202 | 0 | 1 | 2 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification |
| GO:0060615 | 0.04801 | 40.22202 | 0 | 1 | 2 | mammary gland bud formation |
| GO:0060667 | 0.04801 | 40.22202 | 0 | 1 | 2 | branch elongation involved in salivary gland morphogenesis |
| GO:0060721 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of spongiotrophoblast cell proliferation |
| GO:0060723 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of cell proliferation involved in embryonic placenta development |
| GO:0060915 | 0.04801 | 40.22202 | 0 | 1 | 2 | mesenchymal cell differentiation involved in lung development |
| GO:0061017 | 0.04801 | 40.22202 | 0 | 1 | 2 | hepatoblast differentiation |
| GO:0061102 | 0.04801 | 40.22202 | 0 | 1 | 2 | stomach neuroendocrine cell differentiation |
| GO:0061104 | 0.04801 | 40.22202 | 0 | 1 | 2 | adrenal chromaffin cell differentiation |
| GO:0061107 | 0.04801 | 40.22202 | 0 | 1 | 2 | seminal vesicle development |
| GO:0061402 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH |
| GO:0061723 | 0.04801 | 40.22202 | 0 | 1 | 2 | glycophagy |
| GO:0061872 | 0.04801 | 40.22202 | 0 | 1 | 2 | hepatic stellate cell contraction |
| GO:0061873 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of hepatic stellate cell contraction |
| GO:0062044 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of cardiac epithelial to mesenchymal transition |
| GO:0070165 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0070171 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of tooth mineralization |
| GO:0071461 | 0.04801 | 40.22202 | 0 | 1 | 2 | cellular response to redox state |
| GO:0071626 | 0.04801 | 40.22202 | 0 | 1 | 2 | mastication |
| GO:0071879 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0072114 | 0.04801 | 40.22202 | 0 | 1 | 2 | pronephros morphogenesis |
| GO:0072181 | 0.04801 | 40.22202 | 0 | 1 | 2 | mesonephric duct formation |
| GO:0097089 | 0.04801 | 40.22202 | 0 | 1 | 2 | methyl-branched fatty acid metabolic process |
| GO:0098583 | 0.04801 | 40.22202 | 0 | 1 | 2 | learned vocalization behavior |
| GO:0098923 | 0.04801 | 40.22202 | 0 | 1 | 2 | retrograde trans-synaptic signaling by soluble gas |
| GO:0098924 | 0.04801 | 40.22202 | 0 | 1 | 2 | retrograde trans-synaptic signaling by nitric oxide |
| GO:0099148 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of synaptic vesicle docking |
| GO:0099642 | 0.04801 | 40.22202 | 0 | 1 | 2 | retrograde axonal protein transport |
| GO:1900154 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of bone trabecula formation |
| GO:1900155 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:1900924 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of glycine import across plasma membrane |
| GO:1901052 | 0.04801 | 40.22202 | 0 | 1 | 2 | sarcosine metabolic process |
| GO:1901624 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of lymphocyte chemotaxis |
| GO:1902068 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of sphingolipid mediated signaling pathway |
| GO:1902767 | 0.04801 | 40.22202 | 0 | 1 | 2 | isoprenoid biosynthetic process via mevalonate |
| GO:1902954 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of early endosome to recycling endosome transport |
| GO:1902960 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902962 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902963 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902988 | 0.04801 | 40.22202 | 0 | 1 | 2 | neurofibrillary tangle assembly |
| GO:1902996 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of neurofibrillary tangle assembly |
| GO:1903905 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of establishment of T cell polarity |
| GO:1904046 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of vascular endothelial growth factor production |
| GO:1904049 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of spontaneous neurotransmitter secretion |
| GO:1904305 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of gastro-intestinal system smooth muscle contraction |
| GO:1904348 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of small intestine smooth muscle contraction |
| GO:1904397 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of neuromuscular junction development |
| GO:1904456 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of neuronal action potential |
| GO:1904691 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of type B pancreatic cell proliferation |
| GO:1905006 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:1905246 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of aspartic-type peptidase activity |
| GO:1905627 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of serotonin biosynthetic process |
| GO:1905747 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of saliva secretion |
| GO:1905748 | 0.04801 | 40.22202 | 0 | 1 | 2 | hard palate morphogenesis |
| GO:1990079 | 0.04801 | 40.22202 | 0 | 1 | 2 | cartilage homeostasis |
| GO:1990443 | 0.04801 | 40.22202 | 0 | 1 | 2 | peptidyl-threonine autophosphorylation |
| GO:1990911 | 0.04801 | 40.22202 | 0 | 1 | 2 | response to psychosocial stress |
| GO:2000098 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000485 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of glutamine transport |
| GO:2000575 | 0.04801 | 40.22202 | 0 | 1 | 2 | negative regulation of microtubule motor activity |
| GO:2000724 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of cardiac vascular smooth muscle cell differentiation |
| GO:2000830 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of parathyroid hormone secretion |
| GO:2001035 | 0.04801 | 40.22202 | 0 | 1 | 2 | regulation of tongue muscle cell differentiation |
| GO:2001037 | 0.04801 | 40.22202 | 0 | 1 | 2 | positive regulation of tongue muscle cell differentiation |
| GO:0006820 | 0.04840 | 1.53710 | 13 | 20 | 549 | anion transport |
| GO:0017158 | 0.04857 | 2.19363 | 3 | 7 | 136 | regulation of calcium ion-dependent exocytosis |
| GO:0071407 | 0.04858 | 1.57602 | 12 | 18 | 482 | cellular response to organic cyclic compound |
| GO:0007179 | 0.04887 | 2.06104 | 4 | 8 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0060512 | 0.04896 | 3.90116 | 1 | 3 | 34 | prostate gland morphogenesis |
| GO:0044255 | 0.04903 | 1.40368 | 23 | 31 | 932 | cellular lipid metabolic process |
| GO:0006637 | 0.04946 | 2.62168 | 2 | 5 | 82 | acyl-CoA metabolic process |
| GO:0035383 | 0.04946 | 2.62168 | 2 | 5 | 82 | thioester metabolic process |
| GO:0046364 | 0.04946 | 2.62168 | 2 | 5 | 82 | monosaccharide biosynthetic process |
| GO:0002067 | 0.04963 | 3.04488 | 1 | 4 | 57 | glandular epithelial cell differentiation |
| GO:0042551 | 0.04963 | 3.04488 | 1 | 4 | 57 | neuron maturation |
| GO:0051893 | 0.04963 | 3.04488 | 1 | 4 | 57 | regulation of focal adhesion assembly |
| GO:0090109 | 0.04963 | 3.04488 | 1 | 4 | 57 | regulation of cell-substrate junction assembly |
| GO:0099172 | 0.04963 | 3.04488 | 1 | 4 | 57 | presynapse organization |
| GO:0007548 | 0.04996 | 1.76197 | 7 | 12 | 288 | sex differentiation |